IL295616A - Adapted cells and treatment methods - Google Patents

Info

Publication number

IL295616A

IL295616A IL295616A IL29561622A IL295616A IL 295616 A IL295616 A IL 295616A IL 295616 A IL295616 A IL 295616A IL 29561622 A IL29561622 A IL 29561622A IL 295616 A IL295616 A IL 295616A

Authority

IL

Israel

Prior art keywords

cell

receptor

gene

tcr

sequence

Prior art date

2015-07-31

Links

• Espacenet
• Global Dossier
• Discuss

• 238000000034 method Methods 0.000 title claims description 203
• 238000002560 therapeutic procedure Methods 0.000 title description 2
• 210000004027 cell Anatomy 0.000 claims description 406
• 108091008874 T cell receptors Proteins 0.000 claims description 251
• 102000016266 T-Cell Antigen Receptors Human genes 0.000 claims description 244
• 108090000623 proteins and genes Proteins 0.000 claims description 235
• 102000040430 polynucleotide Human genes 0.000 claims description 185
• 108091033319 polynucleotide Proteins 0.000 claims description 185
• 150000007523 nucleic acids Chemical class 0.000 claims description 154
• 210000001744 T-lymphocyte Anatomy 0.000 claims description 153
• 102000039446 nucleic acids Human genes 0.000 claims description 150
• 108020004707 nucleic acids Proteins 0.000 claims description 150
• 102100040678 Programmed cell death protein 1 Human genes 0.000 claims description 108
• 101710089372 Programmed cell death protein 1 Proteins 0.000 claims description 108
• 108091033409 CRISPR Proteins 0.000 claims description 100
• 108020005004 Guide RNA Proteins 0.000 claims description 86
• 229940045513 CTLA4 antagonist Drugs 0.000 claims description 79
• 102000004169 proteins and genes Human genes 0.000 claims description 75
• 238000010354 CRISPR gene editing Methods 0.000 claims description 74
• 102100039498 Cytotoxic T-lymphocyte protein 4 Human genes 0.000 claims description 71
• 235000018102 proteins Nutrition 0.000 claims description 71
• 108010092799 RNA-directed DNA polymerase Proteins 0.000 claims description 68
• 125000003729 nucleotide group Chemical group 0.000 claims description 67
• 239000002773 nucleotide Substances 0.000 claims description 66
• 238000002744 homologous recombination Methods 0.000 claims description 56
• 230000006801 homologous recombination Effects 0.000 claims description 56
• 230000005782 double-strand break Effects 0.000 claims description 50
• 230000006798 recombination Effects 0.000 claims description 49
• 238000005215 recombination Methods 0.000 claims description 49
• 238000003780 insertion Methods 0.000 claims description 48
• 230000037431 insertion Effects 0.000 claims description 48
• 239000003623 enhancer Substances 0.000 claims description 46
• 230000004048 modification Effects 0.000 claims description 44
• 238000012986 modification Methods 0.000 claims description 44
• 230000037361 pathway Effects 0.000 claims description 44
• 150000001875 compounds Chemical class 0.000 claims description 41
• 102100035875 C-C chemokine receptor type 5 Human genes 0.000 claims description 39
• 230000010354 integration Effects 0.000 claims description 37
• 101710163270 Nuclease Proteins 0.000 claims description 36
• 102000005962 receptors Human genes 0.000 claims description 35
• 108020003175 receptors Proteins 0.000 claims description 35
• 101000889276 Homo sapiens Cytotoxic T-lymphocyte protein 4 Proteins 0.000 claims description 34
• 230000000295 complement effect Effects 0.000 claims description 33
• 101000988834 Homo sapiens Hypoxanthine-guanine phosphoribosyltransferase Proteins 0.000 claims description 32
• 238000004520 electroporation Methods 0.000 claims description 31
• 102100029098 Hypoxanthine-guanine phosphoribosyltransferase Human genes 0.000 claims description 30
• 210000004698 lymphocyte Anatomy 0.000 claims description 30
• 239000003607 modifier Substances 0.000 claims description 30
• 239000000203 mixture Substances 0.000 claims description 29
• 239000002157 polynucleotide Substances 0.000 claims description 29
• 102100029822 B- and T-lymphocyte attenuator Human genes 0.000 claims description 28
• 102100034458 Hepatitis A virus cellular receptor 2 Human genes 0.000 claims description 28
• 101000864344 Homo sapiens B- and T-lymphocyte attenuator Proteins 0.000 claims description 28
• 101001137987 Homo sapiens Lymphocyte activation gene 3 protein Proteins 0.000 claims description 28
• 102100040061 Indoleamine 2,3-dioxygenase 1 Human genes 0.000 claims description 28
• 102100033627 Killer cell immunoglobulin-like receptor 3DL1 Human genes 0.000 claims description 28
• 102100020862 Lymphocyte activation gene 3 protein Human genes 0.000 claims description 28
• 108020004999 messenger RNA Proteins 0.000 claims description 28
• 101710149870 C-C chemokine receptor type 5 Proteins 0.000 claims description 27
• 108010007707 Hepatitis A Virus Cellular Receptor 2 Proteins 0.000 claims description 26
• 101000945351 Homo sapiens Killer cell immunoglobulin-like receptor 3DL1 Proteins 0.000 claims description 26
• 101710120843 Indoleamine 2,3-dioxygenase 1 Proteins 0.000 claims description 26
• 102100038082 Natural killer cell receptor 2B4 Human genes 0.000 claims description 26
• 102100038929 V-set domain-containing T-cell activation inhibitor 1 Human genes 0.000 claims description 26
• 230000034431 double-strand break repair via homologous recombination Effects 0.000 claims description 26
• 108090000765 processed proteins & peptides Proteins 0.000 claims description 26
• 108020004414 DNA Proteins 0.000 claims description 24
• 238000010362 genome editing Methods 0.000 claims description 24
• 108010019670 Chimeric Antigen Receptors Proteins 0.000 claims description 23
• 230000027455 binding Effects 0.000 claims description 21
• 230000008685 targeting Effects 0.000 claims description 21
• 239000013598 vector Substances 0.000 claims description 21
• 230000006044 T cell activation Effects 0.000 claims description 20
• 230000011664 signaling Effects 0.000 claims description 20
• 102000004127 Cytokines Human genes 0.000 claims description 18
• 108090000695 Cytokines Proteins 0.000 claims description 18
• 102100031780 Endonuclease Human genes 0.000 claims description 18
• 108010042407 Endonucleases Proteins 0.000 claims description 18
• -1 Cpfl Proteins 0.000 claims description 17
• 230000006870 function Effects 0.000 claims description 17
• 102100038078 CD276 antigen Human genes 0.000 claims description 16
• 108090000426 Caspase-1 Proteins 0.000 claims description 16
• 102000005768 DNA-Activated Protein Kinase Human genes 0.000 claims description 16
• 108010006124 DNA-Activated Protein Kinase Proteins 0.000 claims description 16
• 102100033996 Double-strand break repair protein MRE11 Human genes 0.000 claims description 16
• 101710120363 Double-strand break repair protein MRE11 Proteins 0.000 claims description 16
• 108060003951 Immunoglobulin Proteins 0.000 claims description 16
• 102000018358 immunoglobulin Human genes 0.000 claims description 16
• 241000702421 Dependoparvovirus Species 0.000 claims description 15
• 101000833614 Homo sapiens Interferon-inducible protein AIM2 Proteins 0.000 claims description 15
• 108091008036 Immune checkpoint proteins Proteins 0.000 claims description 15
• 102100024064 Interferon-inducible protein AIM2 Human genes 0.000 claims description 15
• 230000001086 cytosolic effect Effects 0.000 claims description 15
• 210000002865 immune cell Anatomy 0.000 claims description 15
• 102000004196 processed proteins & peptides Human genes 0.000 claims description 15
• 102000007471 Adenosine A2A receptor Human genes 0.000 claims description 14
• 108010085277 Adenosine A2A receptor Proteins 0.000 claims description 14
• 108091008875 B cell receptors Proteins 0.000 claims description 14
• 102100035904 Caspase-1 Human genes 0.000 claims description 14
• 101000884279 Homo sapiens CD276 antigen Proteins 0.000 claims description 14
• 101710141230 Natural killer cell receptor 2B4 Proteins 0.000 claims description 14
• 108010079206 V-Set Domain-Containing T-Cell Activation Inhibitor 1 Proteins 0.000 claims description 14
• 102100040310 Z-DNA-binding protein 1 Human genes 0.000 claims description 14
• 230000001939 inductive effect Effects 0.000 claims description 13
• 229920001184 polypeptide Polymers 0.000 claims description 13
• 101000946926 Homo sapiens C-C chemokine receptor type 5 Proteins 0.000 claims description 12
• 101000884270 Homo sapiens Natural killer cell receptor 2B4 Proteins 0.000 claims description 12
• 101000955999 Homo sapiens V-set domain-containing T-cell activation inhibitor 1 Proteins 0.000 claims description 12
• 230000036755 cellular response Effects 0.000 claims description 10
• 230000007541 cellular toxicity Effects 0.000 claims description 10
• 101710181770 Z-DNA-binding protein 1 Proteins 0.000 claims description 9
• 238000003776 cleavage reaction Methods 0.000 claims description 9
• 230000001105 regulatory effect Effects 0.000 claims description 9
• 230000008439 repair process Effects 0.000 claims description 9
• 230000007017 scission Effects 0.000 claims description 9
• 125000006850 spacer group Chemical group 0.000 claims description 9
• 102100032218 Cytokine-inducible SH2-containing protein Human genes 0.000 claims description 8
• 238000010459 TALEN Methods 0.000 claims description 8
• 108010012154 cytokine inducible SH2-containing protein Proteins 0.000 claims description 8
• 102000011931 Nucleoproteins Human genes 0.000 claims description 7
• 108010061100 Nucleoproteins Proteins 0.000 claims description 7
• 210000005260 human cell Anatomy 0.000 claims description 7
• XRILCFTWUCUKJR-INFSMZHSSA-N 2'-3'-cGAMP Chemical compound C([C@H]([C@H]1O)O2)OP(O)(=O)O[C@H]3[C@@H](O)[C@H](N4C5=NC=NC(N)=C5N=C4)O[C@@H]3COP(O)(=O)O[C@H]1[C@@H]2N1C=NC2=C1NC(N)=NC2=O XRILCFTWUCUKJR-INFSMZHSSA-N 0.000 claims description 6
• 102000006306 Antigen Receptors Human genes 0.000 claims description 6
• 108010083359 Antigen Receptors Proteins 0.000 claims description 6
• 108060002716 Exonuclease Proteins 0.000 claims description 6
• 102000000589 Interleukin-1 Human genes 0.000 claims description 6
• 108010002352 Interleukin-1 Proteins 0.000 claims description 6
• 102000013165 exonuclease Human genes 0.000 claims description 6
• 238000004519 manufacturing process Methods 0.000 claims description 6
• 210000004986 primary T-cell Anatomy 0.000 claims description 6
• 230000002441 reversible effect Effects 0.000 claims description 6
• 102000005927 Cysteine Proteases Human genes 0.000 claims description 5
• 108010005843 Cysteine Proteases Proteins 0.000 claims description 5
• 101000964436 Homo sapiens Z-DNA-binding protein 1 Proteins 0.000 claims description 5
• CKLJMWTZIZZHCS-REOHCLBHSA-N L-aspartic acid Chemical compound OC(=O)[C@@H](N)CC(O)=O CKLJMWTZIZZHCS-REOHCLBHSA-N 0.000 claims description 5
• 108091000080 Phosphotransferase Proteins 0.000 claims description 5
• 229940009098 aspartate Drugs 0.000 claims description 5
• 102000020233 phosphotransferase Human genes 0.000 claims description 5
• 210000003171 tumor-infiltrating lymphocyte Anatomy 0.000 claims description 5
• 229940076838 Immune checkpoint inhibitor Drugs 0.000 claims description 4
• 108010083644 Ribonucleases Proteins 0.000 claims description 4
• 102000006382 Ribonucleases Human genes 0.000 claims description 4
• 239000012274 immune-checkpoint protein inhibitor Substances 0.000 claims description 4
• 230000004853 protein function Effects 0.000 claims description 2
• 108010074708 B7-H1 Antigen Proteins 0.000 claims 2
• 102100024216 Programmed cell death 1 ligand 1 Human genes 0.000 claims 2
• 239000013607 AAV vector Substances 0.000 claims 1
• 108010088141 Argonaute Proteins Proteins 0.000 claims 1
• 102000008682 Argonaute Proteins Human genes 0.000 claims 1
• 108010043645 Transcription Activator-Like Effector Nucleases Proteins 0.000 claims 1
• 102000008579 Transposases Human genes 0.000 claims 1
• 108010020764 Transposases Proteins 0.000 claims 1
• 101150022482 zen gene Proteins 0.000 claims 1
• 108700019146 Transgenes Proteins 0.000 description 176
• 206010028980 Neoplasm Diseases 0.000 description 82
• 102100034343 Integrase Human genes 0.000 description 71
• 229920002477 rna polymer Polymers 0.000 description 71
• 201000011510 cancer Diseases 0.000 description 48
• 230000014509 gene expression Effects 0.000 description 48
• 238000001890 transfection Methods 0.000 description 46
• 239000013603 viral vector Substances 0.000 description 46
• 239000000427 antigen Substances 0.000 description 45
• 108010021064 CTLA-4 Antigen Proteins 0.000 description 39
• 102000036639 antigens Human genes 0.000 description 37
• 108091007433 antigens Proteins 0.000 description 37
• 210000000130 stem cell Anatomy 0.000 description 32
• 230000000694 effects Effects 0.000 description 27
• 230000001900 immune effect Effects 0.000 description 24
• 230000003612 virological effect Effects 0.000 description 23
• 239000013612 plasmid Substances 0.000 description 22
• 230000035899 viability Effects 0.000 description 22
• 230000035772 mutation Effects 0.000 description 21
• 108010050904 Interferons Proteins 0.000 description 20
• 102000053602 DNA Human genes 0.000 description 19
• 230000003013 cytotoxicity Effects 0.000 description 18
• 231100000135 cytotoxicity Toxicity 0.000 description 18
• 239000011324 bead Substances 0.000 description 17
• 230000011987 methylation Effects 0.000 description 16
• 238000007069 methylation reaction Methods 0.000 description 16
• 230000006780 non-homologous end joining Effects 0.000 description 16
• 102000014150 Interferons Human genes 0.000 description 15
• 238000012413 Fluorescence activated cell sorting analysis Methods 0.000 description 14
• 230000004913 activation Effects 0.000 description 14
• 238000007792 addition Methods 0.000 description 14
• 238000010804 cDNA synthesis Methods 0.000 description 14
• 239000003112 inhibitor Substances 0.000 description 14
• 229940079322 interferon Drugs 0.000 description 14
• 108020004635 Complementary DNA Proteins 0.000 description 13
• 239000002299 complementary DNA Substances 0.000 description 13
• 238000011194 good manufacturing practice Methods 0.000 description 13
• 230000001965 increasing effect Effects 0.000 description 13
• 210000004940 nucleus Anatomy 0.000 description 13
• 230000008569 process Effects 0.000 description 13
• 108700018351 Major Histocompatibility Complex Proteins 0.000 description 12
• 238000004458 analytical method Methods 0.000 description 12
• 230000003172 anti-dna Effects 0.000 description 12
• 238000003556 assay Methods 0.000 description 12
• 238000012217 deletion Methods 0.000 description 12
• 230000037430 deletion Effects 0.000 description 12
• 239000012528 membrane Substances 0.000 description 12
• 238000012163 sequencing technique Methods 0.000 description 12
• 230000020382 suppression by virus of host antigen processing and presentation of peptide antigen via MHC class I Effects 0.000 description 12
• 238000013518 transcription Methods 0.000 description 12
• 230000035897 transcription Effects 0.000 description 12
• 108010076667 Caspases Proteins 0.000 description 11
• 102000011727 Caspases Human genes 0.000 description 11
• 230000003834 intracellular effect Effects 0.000 description 11
• 210000004379 membrane Anatomy 0.000 description 11
• YBJHBAHKTGYVGT-ZKWXMUAHSA-N (+)-Biotin Chemical compound N1C(=O)N[C@@H]2[C@H](CCCCC(=O)O)SC[C@@H]21 YBJHBAHKTGYVGT-ZKWXMUAHSA-N 0.000 description 10
• 101000914514 Homo sapiens T-cell-specific surface glycoprotein CD28 Proteins 0.000 description 10
• 102100027213 T-cell-specific surface glycoprotein CD28 Human genes 0.000 description 10
• 230000001413 cellular effect Effects 0.000 description 10
• RYYWUUFWQRZTIU-UHFFFAOYSA-K thiophosphate Chemical group [O-]P([O-])([O-])=S RYYWUUFWQRZTIU-UHFFFAOYSA-K 0.000 description 10
• 102000003810 Interleukin-18 Human genes 0.000 description 9
• 108090000171 Interleukin-18 Proteins 0.000 description 9
• 108010077850 Nuclear Localization Signals Proteins 0.000 description 9
• 102100038192 Serine/threonine-protein kinase TBK1 Human genes 0.000 description 9
• 101710106944 Serine/threonine-protein kinase TBK1 Proteins 0.000 description 9
• FUHMZYWBSHTEDZ-UHFFFAOYSA-M bispyribac-sodium Chemical compound [Na+].COC1=CC(OC)=NC(OC=2C(=C(OC=3N=C(OC)C=C(OC)N=3)C=CC=2)C([O-])=O)=N1 FUHMZYWBSHTEDZ-UHFFFAOYSA-M 0.000 description 9
• 239000003795 chemical substances by application Substances 0.000 description 9
• 230000009977 dual effect Effects 0.000 description 9
• 230000004797 therapeutic response Effects 0.000 description 9
• 102100027286 Fanconi anemia group C protein Human genes 0.000 description 8
• 241000700605 Viruses Species 0.000 description 8
• 102100036976 X-ray repair cross-complementing protein 6 Human genes 0.000 description 8
• 230000030833 cell death Effects 0.000 description 8
• 230000003833 cell viability Effects 0.000 description 8
• 230000008859 change Effects 0.000 description 8
• 231100000433 cytotoxic Toxicity 0.000 description 8
• 230000001472 cytotoxic effect Effects 0.000 description 8
• 102000037865 fusion proteins Human genes 0.000 description 8
• 108020001507 fusion proteins Proteins 0.000 description 8
• 210000003958 hematopoietic stem cell Anatomy 0.000 description 8
• 238000000338 in vitro Methods 0.000 description 8
• 239000000126 substance Substances 0.000 description 8
• 238000012546 transfer Methods 0.000 description 8
• 238000011282 treatment Methods 0.000 description 8
• 102100037249 Egl nine homolog 1 Human genes 0.000 description 7
• 101000611936 Homo sapiens Programmed cell death protein 1 Proteins 0.000 description 7
• 101000657330 Homo sapiens TRAF family member-associated NF-kappa-B activator Proteins 0.000 description 7
• 108010002350 Interleukin-2 Proteins 0.000 description 7
• 102000000588 Interleukin-2 Human genes 0.000 description 7
• 102100037248 Prolyl hydroxylase EGLN2 Human genes 0.000 description 7
• 102100037247 Prolyl hydroxylase EGLN3 Human genes 0.000 description 7
• 101710188315 Protein X Proteins 0.000 description 7
• 108091027981 Response element Proteins 0.000 description 7
• 102100034779 TRAF family member-associated NF-kappa-B activator Human genes 0.000 description 7
• 102100024855 Three-prime repair exonuclease 1 Human genes 0.000 description 7
• 108010067390 Viral Proteins Proteins 0.000 description 7
• 230000006907 apoptotic process Effects 0.000 description 7
• 230000001580 bacterial effect Effects 0.000 description 7
• 238000006243 chemical reaction Methods 0.000 description 7
• 239000003446 ligand Substances 0.000 description 7
• 238000001638 lipofection Methods 0.000 description 7
• 230000030648 nucleus localization Effects 0.000 description 7
• 210000005105 peripheral blood lymphocyte Anatomy 0.000 description 7
• 230000000638 stimulation Effects 0.000 description 7
• 230000001225 therapeutic effect Effects 0.000 description 7
• 108010036169 three prime repair exonuclease 1 Proteins 0.000 description 7
• 238000010361 transduction Methods 0.000 description 7
• 230000026683 transduction Effects 0.000 description 7
• 102000003812 Interleukin-15 Human genes 0.000 description 6
• 108090000172 Interleukin-15 Proteins 0.000 description 6
• 101710173438 Late L2 mu core protein Proteins 0.000 description 6
• MIFGOLAMNLSLGH-QOKNQOGYSA-N Z-Val-Ala-Asp(OMe)-CH2F Chemical compound COC(=O)C[C@@H](C(=O)CF)NC(=O)[C@H](C)NC(=O)[C@H](C(C)C)NC(=O)OCC1=CC=CC=C1 MIFGOLAMNLSLGH-QOKNQOGYSA-N 0.000 description 6
• 230000004075 alteration Effects 0.000 description 6
• 230000000259 anti-tumor effect Effects 0.000 description 6
• 238000013459 approach Methods 0.000 description 6
• 230000015572 biosynthetic process Effects 0.000 description 6
• 229960002685 biotin Drugs 0.000 description 6
• 239000011616 biotin Substances 0.000 description 6
• 238000001727 in vivo Methods 0.000 description 6
• 208000015181 infectious disease Diseases 0.000 description 6
• 230000004060 metabolic process Effects 0.000 description 6
• 239000002245 particle Substances 0.000 description 6
• 239000000047 product Substances 0.000 description 6
• 210000001519 tissue Anatomy 0.000 description 6
• 230000001988 toxicity Effects 0.000 description 6
• 231100000419 toxicity Toxicity 0.000 description 6
• 108091032973 (ribonucleotides)n+m Proteins 0.000 description 5
• 102000040650 (ribonucleotides)n+m Human genes 0.000 description 5
• 108010004586 Ataxia Telangiectasia Mutated Proteins Proteins 0.000 description 5
• 102100027207 CD27 antigen Human genes 0.000 description 5
• 102000004190 Enzymes Human genes 0.000 description 5
• 108090000790 Enzymes Proteins 0.000 description 5
• 101000914511 Homo sapiens CD27 antigen Proteins 0.000 description 5
• 108010061833 Integrases Proteins 0.000 description 5
• 108010032038 Interferon Regulatory Factor-3 Proteins 0.000 description 5
• 102100029843 Interferon regulatory factor 3 Human genes 0.000 description 5
• 102000003960 Ligases Human genes 0.000 description 5
• 108090000364 Ligases Proteins 0.000 description 5
• 108091028043 Nucleic acid sequence Proteins 0.000 description 5
• 108091034117 Oligonucleotide Proteins 0.000 description 5
• 102100035620 Protein phosphatase 1 regulatory subunit 12C Human genes 0.000 description 5
• 108050008721 Protein phosphatase 1 regulatory subunit 12C Proteins 0.000 description 5
• 102000018120 Recombinases Human genes 0.000 description 5
• 108010091086 Recombinases Proteins 0.000 description 5
• 108020004682 Single-Stranded DNA Proteins 0.000 description 5
• 239000012190 activator Substances 0.000 description 5
• 230000000735 allogeneic effect Effects 0.000 description 5
• 235000020958 biotin Nutrition 0.000 description 5
• 230000010261 cell growth Effects 0.000 description 5
• 230000007423 decrease Effects 0.000 description 5
• 229940088598 enzyme Drugs 0.000 description 5
• 230000007717 exclusion Effects 0.000 description 5
• 238000009169 immunotherapy Methods 0.000 description 5
• 230000000670 limiting effect Effects 0.000 description 5
• 230000001404 mediated effect Effects 0.000 description 5
• 230000002503 metabolic effect Effects 0.000 description 5
• 238000000520 microinjection Methods 0.000 description 5
• 230000036961 partial effect Effects 0.000 description 5
• 230000009467 reduction Effects 0.000 description 5
• 230000004044 response Effects 0.000 description 5
• 238000012360 testing method Methods 0.000 description 5
• 238000013519 translation Methods 0.000 description 5
• 102100022410 ATP-dependent DNA/RNA helicase DHX36 Human genes 0.000 description 4
• 102100029647 Apoptosis-associated speck-like protein containing a CARD Human genes 0.000 description 4
• 101710139398 Apoptosis-associated speck-like protein containing a CARD Proteins 0.000 description 4
• 102100022970 Basic leucine zipper transcriptional factor ATF-like Human genes 0.000 description 4
• 102100024263 CD160 antigen Human genes 0.000 description 4
• 102100035793 CD83 antigen Human genes 0.000 description 4
• 108010069682 CSK Tyrosine-Protein Kinase Proteins 0.000 description 4
• 108090000397 Caspase 3 Proteins 0.000 description 4
• 102000004018 Caspase 6 Human genes 0.000 description 4
• 108090000425 Caspase 6 Proteins 0.000 description 4
• 108090000567 Caspase 7 Proteins 0.000 description 4
• 102100029855 Caspase-3 Human genes 0.000 description 4
• 102100038902 Caspase-7 Human genes 0.000 description 4
• 102100026548 Caspase-8 Human genes 0.000 description 4
• 108090000538 Caspase-8 Proteins 0.000 description 4
• 102100031256 Cyclic GMP-AMP synthase Human genes 0.000 description 4
• 108030002637 Cyclic GMP-AMP synthases Proteins 0.000 description 4
• 102100027816 Cytotoxic and regulatory T-cell molecule Human genes 0.000 description 4
• 102100029503 E3 ubiquitin-protein ligase TRIM32 Human genes 0.000 description 4
• 102100029713 E3 ubiquitin-protein ligase TRIM56 Human genes 0.000 description 4
• LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 4
• 102100026693 FAS-associated death domain protein Human genes 0.000 description 4
• 102100027581 Forkhead box protein P3 Human genes 0.000 description 4
• 208000009329 Graft vs Host Disease Diseases 0.000 description 4
• 102100040754 Guanylate cyclase soluble subunit alpha-1 Human genes 0.000 description 4
• 102100040735 Guanylate cyclase soluble subunit alpha-2 Human genes 0.000 description 4
• 102100040739 Guanylate cyclase soluble subunit beta-1 Human genes 0.000 description 4
• 102100028963 Guanylate cyclase soluble subunit beta-2 Human genes 0.000 description 4
• 102100028008 Heme oxygenase 2 Human genes 0.000 description 4
• 101000901942 Homo sapiens ATP-dependent DNA/RNA helicase DHX36 Proteins 0.000 description 4
• 101000903742 Homo sapiens Basic leucine zipper transcriptional factor ATF-like Proteins 0.000 description 4
• 101000761938 Homo sapiens CD160 antigen Proteins 0.000 description 4
• 101000946856 Homo sapiens CD83 antigen Proteins 0.000 description 4
• 101000634982 Homo sapiens E3 ubiquitin-protein ligase TRIM32 Proteins 0.000 description 4
• 101000795363 Homo sapiens E3 ubiquitin-protein ligase TRIM56 Proteins 0.000 description 4
• 101000881648 Homo sapiens Egl nine homolog 1 Proteins 0.000 description 4
• 101000911074 Homo sapiens FAS-associated death domain protein Proteins 0.000 description 4
• 101000861452 Homo sapiens Forkhead box protein P3 Proteins 0.000 description 4
• 101001038755 Homo sapiens Guanylate cyclase soluble subunit alpha-1 Proteins 0.000 description 4
• 101001038749 Homo sapiens Guanylate cyclase soluble subunit alpha-2 Proteins 0.000 description 4
• 101001038731 Homo sapiens Guanylate cyclase soluble subunit beta-1 Proteins 0.000 description 4
• 101001059095 Homo sapiens Guanylate cyclase soluble subunit beta-2 Proteins 0.000 description 4
• 101001018097 Homo sapiens L-selectin Proteins 0.000 description 4
• 101000763322 Homo sapiens M1-specific T cell receptor beta chain Proteins 0.000 description 4
• 101000692259 Homo sapiens Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 Proteins 0.000 description 4
• 101000881650 Homo sapiens Prolyl hydroxylase EGLN2 Proteins 0.000 description 4
• 101000881678 Homo sapiens Prolyl hydroxylase EGLN3 Proteins 0.000 description 4
• 101000688930 Homo sapiens Signaling threshold-regulating transmembrane adapter 1 Proteins 0.000 description 4
• 101000863692 Homo sapiens Ski oncogene Proteins 0.000 description 4
• 101000688996 Homo sapiens Ski-like protein Proteins 0.000 description 4
• 101000763321 Homo sapiens T cell receptor beta chain MC.7.G5 Proteins 0.000 description 4
• 101000596234 Homo sapiens T-cell surface protein tactile Proteins 0.000 description 4
• 101000914484 Homo sapiens T-lymphocyte activation antigen CD80 Proteins 0.000 description 4
• 101000712669 Homo sapiens TGF-beta receptor type-2 Proteins 0.000 description 4
• 101000804928 Homo sapiens X-ray repair cross-complementing protein 6 Proteins 0.000 description 4
• 241000713772 Human immunodeficiency virus 1 Species 0.000 description 4
• 108010044240 IFIH1 Interferon-Induced Helicase Proteins 0.000 description 4
• 102000037982 Immune checkpoint proteins Human genes 0.000 description 4
• 102000007576 Interferon Regulatory Factor-7 Human genes 0.000 description 4
• 108010032036 Interferon Regulatory Factor-7 Proteins 0.000 description 4
• 102000004289 Interferon regulatory factor 1 Human genes 0.000 description 4
• 108090000890 Interferon regulatory factor 1 Proteins 0.000 description 4
• 102100027353 Interferon-induced helicase C domain-containing protein 1 Human genes 0.000 description 4
• 102100030703 Interleukin-22 Human genes 0.000 description 4
• 108010038501 Interleukin-6 Receptors Proteins 0.000 description 4
• 102100037792 Interleukin-6 receptor subunit alpha Human genes 0.000 description 4
• 102100037795 Interleukin-6 receptor subunit beta Human genes 0.000 description 4
• 101710152369 Interleukin-6 receptor subunit beta Proteins 0.000 description 4
• 108010002586 Interleukin-7 Proteins 0.000 description 4
• 102100033467 L-selectin Human genes 0.000 description 4
• 239000000232 Lipid Bilayer Substances 0.000 description 4
• 102100026964 M1-specific T cell receptor beta chain Human genes 0.000 description 4
• 102000018697 Membrane Proteins Human genes 0.000 description 4
• 108010052285 Membrane Proteins Proteins 0.000 description 4
• 102100023727 Mitochondrial antiviral-signaling protein Human genes 0.000 description 4
• 101710142315 Mitochondrial antiviral-signaling protein Proteins 0.000 description 4
• 102100025751 Mothers against decapentaplegic homolog 2 Human genes 0.000 description 4
• 101710143123 Mothers against decapentaplegic homolog 2 Proteins 0.000 description 4
• 102100025748 Mothers against decapentaplegic homolog 3 Human genes 0.000 description 4
• 101710143111 Mothers against decapentaplegic homolog 3 Proteins 0.000 description 4
• 102100025725 Mothers against decapentaplegic homolog 4 Human genes 0.000 description 4
• 101710143112 Mothers against decapentaplegic homolog 4 Proteins 0.000 description 4
• 241001529936 Murinae Species 0.000 description 4
• 102100024134 Myeloid differentiation primary response protein MyD88 Human genes 0.000 description 4
• 101710112096 Myeloid differentiation primary response protein MyD88 Proteins 0.000 description 4
• 108010057466 NF-kappa B Proteins 0.000 description 4
• 102000003945 NF-kappa B Human genes 0.000 description 4
• 102000007553 Nucleosome Assembly Protein 1 Human genes 0.000 description 4
• 108010046445 Nucleosome Assembly Protein 1 Proteins 0.000 description 4
• 102100026066 Phosphoprotein associated with glycosphingolipid-enriched microdomains 1 Human genes 0.000 description 4
• 108700008625 Reporter Genes Proteins 0.000 description 4
• 102100029946 Sialic acid-binding Ig-like lectin 7 Human genes 0.000 description 4
• 101710110531 Sialic acid-binding Ig-like lectin 7 Proteins 0.000 description 4
• 102100029965 Sialic acid-binding Ig-like lectin 9 Human genes 0.000 description 4
• 101710110541 Sialic acid-binding Ig-like lectin 9 Proteins 0.000 description 4
• 102100024453 Signaling threshold-regulating transmembrane adapter 1 Human genes 0.000 description 4
• 102100029969 Ski oncogene Human genes 0.000 description 4
• 102100024451 Ski-like protein Human genes 0.000 description 4
• 102100035533 Stimulator of interferon genes protein Human genes 0.000 description 4
• 101710196623 Stimulator of interferon genes protein Proteins 0.000 description 4
• 102100024834 T-cell immunoreceptor with Ig and ITIM domains Human genes 0.000 description 4
• 101710090983 T-cell immunoreceptor with Ig and ITIM domains Proteins 0.000 description 4
• 102100035268 T-cell surface protein tactile Human genes 0.000 description 4
• 102100027222 T-lymphocyte activation antigen CD80 Human genes 0.000 description 4
• 102100033456 TGF-beta receptor type-1 Human genes 0.000 description 4
• 102100033455 TGF-beta receptor type-2 Human genes 0.000 description 4
• 102100033082 TNF receptor-associated factor 3 Human genes 0.000 description 4
• 108090000922 TNF receptor-associated factor 3 Proteins 0.000 description 4
• 108010011702 Transforming Growth Factor-beta Type I Receptor Proteins 0.000 description 4
• 108060008682 Tumor Necrosis Factor Proteins 0.000 description 4
• 102000000852 Tumor Necrosis Factor-alpha Human genes 0.000 description 4
• 102100040403 Tumor necrosis factor receptor superfamily member 6 Human genes 0.000 description 4
• 102100031167 Tyrosine-protein kinase CSK Human genes 0.000 description 4
• 241000700618 Vaccinia virus Species 0.000 description 4
• JLCPHMBAVCMARE-UHFFFAOYSA-N [3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[3-[[3-[[3-[[3-[[3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-[[5-(2-amino-6-oxo-1H-purin-9-yl)-3-hydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxyoxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(5-methyl-2,4-dioxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(6-aminopurin-9-yl)oxolan-2-yl]methoxy-hydroxyphosphoryl]oxy-5-(4-amino-2-oxopyrimidin-1-yl)oxolan-2-yl]methyl [5-(6-aminopurin-9-yl)-2-(hydroxymethyl)oxolan-3-yl] hydrogen phosphate Polymers Cc1cn(C2CC(OP(O)(=O)OCC3OC(CC3OP(O)(=O)OCC3OC(CC3O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c3nc(N)[nH]c4=O)C(COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3COP(O)(=O)OC3CC(OC3CO)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3ccc(N)nc3=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cc(C)c(=O)[nH]c3=O)n3cc(C)c(=O)[nH]c3=O)n3ccc(N)nc3=O)n3cc(C)c(=O)[nH]c3=O)n3cnc4c3nc(N)[nH]c4=O)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)n3cnc4c(N)ncnc34)O2)c(=O)[nH]c1=O JLCPHMBAVCMARE-UHFFFAOYSA-N 0.000 description 4
• 238000002659 cell therapy Methods 0.000 description 4
• 239000013000 chemical inhibitor Substances 0.000 description 4
• 210000000349 chromosome Anatomy 0.000 description 4
• 230000017858 demethylation Effects 0.000 description 4
• 238000010520 demethylation reaction Methods 0.000 description 4
• 230000001419 dependent effect Effects 0.000 description 4
• 108010052621 fas Receptor Proteins 0.000 description 4
• 238000001943 fluorescence-activated cell sorting Methods 0.000 description 4
• 238000010353 genetic engineering Methods 0.000 description 4
• 208000024908 graft versus host disease Diseases 0.000 description 4
• 230000012010 growth Effects 0.000 description 4
• 108010031102 heme oxygenase-2 Proteins 0.000 description 4
• 230000002163 immunogen Effects 0.000 description 4
• 230000002401 inhibitory effect Effects 0.000 description 4
• 108010074108 interleukin-21 Proteins 0.000 description 4
• 229940127255 pan-caspase inhibitor Drugs 0.000 description 4
• 239000013600 plasmid vector Substances 0.000 description 4
• ZCCUUQDIBDJBTK-UHFFFAOYSA-N psoralen Chemical compound C1=C2OC(=O)C=CC2=CC2=C1OC=C2 ZCCUUQDIBDJBTK-UHFFFAOYSA-N 0.000 description 4
• 210000002966 serum Anatomy 0.000 description 4
• LOGFVTREOLYCPF-KXNHARMFSA-N (2s,3r)-2-[[(2r)-1-[(2s)-2,6-diaminohexanoyl]pyrrolidine-2-carbonyl]amino]-3-hydroxybutanoic acid Chemical compound C[C@@H](O)[C@@H](C(O)=O)NC(=O)[C@H]1CCCN1C(=O)[C@@H](N)CCCCN LOGFVTREOLYCPF-KXNHARMFSA-N 0.000 description 3
• 206010069754 Acquired gene mutation Diseases 0.000 description 3
• 208000026310 Breast neoplasm Diseases 0.000 description 3
• 108091079001 CRISPR RNA Proteins 0.000 description 3
• 108091026890 Coding region Proteins 0.000 description 3
• 230000007018 DNA scission Effects 0.000 description 3
• 206010011953 Decreased activity Diseases 0.000 description 3
• 108010008532 Deoxyribonuclease I Proteins 0.000 description 3
• 102000007260 Deoxyribonuclease I Human genes 0.000 description 3
• 101710111663 Egl nine homolog 1 Proteins 0.000 description 3
• PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 3
• 101000634835 Homo sapiens M1-specific T cell receptor alpha chain Proteins 0.000 description 3
• 101000634836 Homo sapiens T cell receptor alpha chain MC.7.G5 Proteins 0.000 description 3
• 101000851370 Homo sapiens Tumor necrosis factor receptor superfamily member 9 Proteins 0.000 description 3
• 229940125581 ImmunityBio COVID-19 vaccine Drugs 0.000 description 3
• 108090000193 Interleukin-1 beta Proteins 0.000 description 3
• 102000003777 Interleukin-1 beta Human genes 0.000 description 3
• 102000000704 Interleukin-7 Human genes 0.000 description 3
• 206010025323 Lymphomas Diseases 0.000 description 3
• 241000699666 Mus <mouse, genus> Species 0.000 description 3
• 206010028851 Necrosis Diseases 0.000 description 3
• 108010077524 Peptide Elongation Factor 1 Proteins 0.000 description 3
• 102000010292 Peptide Elongation Factor 1 Human genes 0.000 description 3
• 102000011755 Phosphoglycerate Kinase Human genes 0.000 description 3
• 101710170760 Prolyl hydroxylase EGLN2 Proteins 0.000 description 3
• 101710170720 Prolyl hydroxylase EGLN3 Proteins 0.000 description 3
• 206010060862 Prostate cancer Diseases 0.000 description 3
• 108010081734 Ribonucleoproteins Proteins 0.000 description 3
• 102000004389 Ribonucleoproteins Human genes 0.000 description 3
• 102100029454 T cell receptor alpha chain MC.7.G5 Human genes 0.000 description 3
• 101001099217 Thermotoga maritima (strain ATCC 43589 / DSM 3109 / JCM 10099 / NBRC 100826 / MSB8) Triosephosphate isomerase Proteins 0.000 description 3
• 108091023040 Transcription factor Proteins 0.000 description 3
• 102100040112 Tumor necrosis factor receptor superfamily member 10B Human genes 0.000 description 3
• 101710178278 Tumor necrosis factor receptor superfamily member 10B Proteins 0.000 description 3
• 102100036856 Tumor necrosis factor receptor superfamily member 9 Human genes 0.000 description 3
• 208000007097 Urinary Bladder Neoplasms Diseases 0.000 description 3
• VEWJOCYCKIZKKV-GBNDHIKLSA-N [[(2r,3s,4r,5s)-5-(2,4-dioxo-1h-pyrimidin-5-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O[C@@H]1[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O[C@H]1C1=CNC(=O)NC1=O VEWJOCYCKIZKKV-GBNDHIKLSA-N 0.000 description 3
• 238000011374 additional therapy Methods 0.000 description 3
• 210000000612 antigen-presenting cell Anatomy 0.000 description 3
• 210000003719 b-lymphocyte Anatomy 0.000 description 3
• 230000008901 benefit Effects 0.000 description 3
• 210000004369 blood Anatomy 0.000 description 3
• 239000008280 blood Substances 0.000 description 3
• KQNZDYYTLMIZCT-KQPMLPITSA-N brefeldin A Chemical compound O[C@@H]1\C=C\C(=O)O[C@@H](C)CCC\C=C\[C@@H]2C[C@H](O)C[C@H]21 KQNZDYYTLMIZCT-KQPMLPITSA-N 0.000 description 3
• JUMGSHROWPPKFX-UHFFFAOYSA-N brefeldin-A Natural products CC1CCCC=CC2(C)CC(O)CC2(C)C(O)C=CC(=O)O1 JUMGSHROWPPKFX-UHFFFAOYSA-N 0.000 description 3
• 230000006037 cell lysis Effects 0.000 description 3
• 230000009087 cell motility Effects 0.000 description 3
• 239000003153 chemical reaction reagent Substances 0.000 description 3
• 238000009833 condensation Methods 0.000 description 3
• 230000005494 condensation Effects 0.000 description 3
• 238000005520 cutting process Methods 0.000 description 3
• 210000004443 dendritic cell Anatomy 0.000 description 3
• 238000013461 design Methods 0.000 description 3
• 238000011161 development Methods 0.000 description 3
• 230000018109 developmental process Effects 0.000 description 3
• 239000000975 dye Substances 0.000 description 3
• 239000012634 fragment Substances 0.000 description 3
• 230000004927 fusion Effects 0.000 description 3
• 238000012239 gene modification Methods 0.000 description 3
• 230000002068 genetic effect Effects 0.000 description 3
• RAXXELZNTBOGNW-UHFFFAOYSA-N imidazole Natural products C1=CNC=N1 RAXXELZNTBOGNW-UHFFFAOYSA-N 0.000 description 3
• 230000028993 immune response Effects 0.000 description 3
• 230000005847 immunogenicity Effects 0.000 description 3
• 238000011065 in-situ storage Methods 0.000 description 3
• 230000005764 inhibitory process Effects 0.000 description 3
• 230000003993 interaction Effects 0.000 description 3
• 210000000265 leukocyte Anatomy 0.000 description 3
• 210000004962 mammalian cell Anatomy 0.000 description 3
• 230000003278 mimic effect Effects 0.000 description 3
• 230000000869 mutational effect Effects 0.000 description 3
• 210000000822 natural killer cell Anatomy 0.000 description 3
• 230000017074 necrotic cell death Effects 0.000 description 3
• 238000005457 optimization Methods 0.000 description 3
• 238000004806 packaging method and process Methods 0.000 description 3
• 239000008194 pharmaceutical composition Substances 0.000 description 3
• 239000000546 pharmaceutical excipient Substances 0.000 description 3
• 229920001606 poly(lactic acid-co-glycolic acid) Polymers 0.000 description 3
• 229920000642 polymer Polymers 0.000 description 3
• 230000035755 proliferation Effects 0.000 description 3
• 238000000746 purification Methods 0.000 description 3
• 239000003642 reactive oxygen metabolite Substances 0.000 description 3
• 230000019491 signal transduction Effects 0.000 description 3
• 239000007787 solid Substances 0.000 description 3
• 230000037439 somatic mutation Effects 0.000 description 3
• 230000004936 stimulating effect Effects 0.000 description 3
• 239000000758 substrate Substances 0.000 description 3
• 230000008961 swelling Effects 0.000 description 3
• 231100000331 toxic Toxicity 0.000 description 3
• 230000002588 toxic effect Effects 0.000 description 3
• 230000009261 transgenic effect Effects 0.000 description 3
• 230000032258 transport Effects 0.000 description 3
• 201000005112 urinary bladder cancer Diseases 0.000 description 3
• VXGRJERITKFWPL-UHFFFAOYSA-N 4',5'-Dihydropsoralen Natural products C1=C2OC(=O)C=CC2=CC2=C1OCC2 VXGRJERITKFWPL-UHFFFAOYSA-N 0.000 description 2
• 108010082808 4-1BB Ligand Proteins 0.000 description 2
• 101150096698 ATG9A gene Proteins 0.000 description 2
• 239000012827 ATM inhibitor Substances 0.000 description 2
• 108010085238 Actins Proteins 0.000 description 2
• 102000007469 Actins Human genes 0.000 description 2
• 102100037435 Antiviral innate immune response receptor RIG-I Human genes 0.000 description 2
• 101710127675 Antiviral innate immune response receptor RIG-I Proteins 0.000 description 2
• 208000023275 Autoimmune disease Diseases 0.000 description 2
• 102100020823 Autophagy-related protein 9A Human genes 0.000 description 2
• 241000713838 Avian myeloblastosis virus Species 0.000 description 2
• 101000840545 Bacillus thuringiensis L-isoleucine-4-hydroxylase Proteins 0.000 description 2
• 206010005003 Bladder cancer Diseases 0.000 description 2
• 206010005949 Bone cancer Diseases 0.000 description 2
• 208000018084 Bone neoplasm Diseases 0.000 description 2
• 208000003174 Brain Neoplasms Diseases 0.000 description 2
• 206010006187 Breast cancer Diseases 0.000 description 2
• 102100036301 C-C chemokine receptor type 7 Human genes 0.000 description 2
• 101150017501 CCR5 gene Proteins 0.000 description 2
• 101710185679 CD276 antigen Proteins 0.000 description 2
• 101150013553 CD40 gene Proteins 0.000 description 2
• 210000001266 CD8-positive T-lymphocyte Anatomy 0.000 description 2
• 229940123169 Caspase inhibitor Drugs 0.000 description 2
• 102100026549 Caspase-10 Human genes 0.000 description 2
• 108090000572 Caspase-10 Proteins 0.000 description 2
• 102100028914 Catenin beta-1 Human genes 0.000 description 2
• 206010009944 Colon cancer Diseases 0.000 description 2
• 101710167716 Cytotoxic and regulatory T-cell molecule Proteins 0.000 description 2
• 230000006820 DNA synthesis Effects 0.000 description 2
• 102000004533 Endonucleases Human genes 0.000 description 2
• 102100029987 Erbin Human genes 0.000 description 2
• 101700035123 Erbin Proteins 0.000 description 2
• 208000000461 Esophageal Neoplasms Diseases 0.000 description 2
• 108091029865 Exogenous DNA Proteins 0.000 description 2
• 102100039928 Gamma-interferon-inducible protein 16 Human genes 0.000 description 2
• WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 2
• 101710083479 Hepatitis A virus cellular receptor 2 homolog Proteins 0.000 description 2
• 101000785057 Homo sapiens Autophagy-related protein 9A Proteins 0.000 description 2
• 101000716065 Homo sapiens C-C chemokine receptor type 7 Proteins 0.000 description 2
• 101000916173 Homo sapiens Catenin beta-1 Proteins 0.000 description 2
• 101000960209 Homo sapiens Gamma-interferon-inducible protein 16 Proteins 0.000 description 2
• 101001037256 Homo sapiens Indoleamine 2,3-dioxygenase 1 Proteins 0.000 description 2
• 101000874165 Homo sapiens Probable ATP-dependent RNA helicase DDX41 Proteins 0.000 description 2
• 101000740162 Homo sapiens Sodium- and chloride-dependent transporter XTRP3 Proteins 0.000 description 2
• 101000635938 Homo sapiens Transforming growth factor beta-1 proprotein Proteins 0.000 description 2
• 101000801234 Homo sapiens Tumor necrosis factor receptor superfamily member 18 Proteins 0.000 description 2
• 241000700588 Human alphaherpesvirus 1 Species 0.000 description 2
• 241000701024 Human betaherpesvirus 5 Species 0.000 description 2
• 241000482741 Human coronavirus NL63 Species 0.000 description 2
• 241000725303 Human immunodeficiency virus Species 0.000 description 2
• 101710090028 Inositol-3-phosphate synthase 1 Proteins 0.000 description 2
• 108010014726 Interferon Type I Proteins 0.000 description 2
• 102000002227 Interferon Type I Human genes 0.000 description 2
• 108010047761 Interferon-alpha Proteins 0.000 description 2
• 102000006992 Interferon-alpha Human genes 0.000 description 2
• 102100030236 Interleukin-10 receptor subunit alpha Human genes 0.000 description 2
• 101710146672 Interleukin-10 receptor subunit alpha Proteins 0.000 description 2
• 102100020788 Interleukin-10 receptor subunit beta Human genes 0.000 description 2
• 101710199214 Interleukin-10 receptor subunit beta Proteins 0.000 description 2
• 102000004889 Interleukin-6 Human genes 0.000 description 2
• 108090001005 Interleukin-6 Proteins 0.000 description 2
• KFZMGEQAYNKOFK-UHFFFAOYSA-N Isopropanol Chemical compound CC(C)O KFZMGEQAYNKOFK-UHFFFAOYSA-N 0.000 description 2
• 108010043610 KIR Receptors Proteins 0.000 description 2
• 208000008839 Kidney Neoplasms Diseases 0.000 description 2
• 108010025026 Ku Autoantigen Proteins 0.000 description 2
• 108010006444 Leucine-Rich Repeat Proteins Proteins 0.000 description 2
• 206010058467 Lung neoplasm malignant Diseases 0.000 description 2
• 241001465754 Metazoa Species 0.000 description 2
• 108060004795 Methyltransferase Proteins 0.000 description 2
• 101100273286 Mus musculus Casp4 gene Proteins 0.000 description 2
• 108091005461 Nucleic proteins Proteins 0.000 description 2
• 108090001074 Nucleocapsid Proteins Proteins 0.000 description 2
• 206010030155 Oesophageal carcinoma Diseases 0.000 description 2
• 206010033128 Ovarian cancer Diseases 0.000 description 2
• 206010061535 Ovarian neoplasm Diseases 0.000 description 2
• 240000007019 Oxalis corniculata Species 0.000 description 2
• 229910019142 PO4 Inorganic materials 0.000 description 2
• 108010067902 Peptide Library Proteins 0.000 description 2
• ISWSIDIOOBJBQZ-UHFFFAOYSA-N Phenol Chemical compound OC1=CC=CC=C1 ISWSIDIOOBJBQZ-UHFFFAOYSA-N 0.000 description 2
• 206010035226 Plasma cell myeloma Diseases 0.000 description 2
• 239000004698 Polyethylene Substances 0.000 description 2
• 239000002202 Polyethylene glycol Substances 0.000 description 2
• 239000004793 Polystyrene Substances 0.000 description 2
• 241001135549 Porcine epidemic diarrhea virus Species 0.000 description 2
• 102100035727 Probable ATP-dependent RNA helicase DDX41 Human genes 0.000 description 2
• 108010043005 Prolyl Hydroxylases Proteins 0.000 description 2
• 102000004079 Prolyl Hydroxylases Human genes 0.000 description 2
• 208000000236 Prostatic Neoplasms Diseases 0.000 description 2
• 229930185560 Pseudouridine Natural products 0.000 description 2
• PTJWIQPHWPFNBW-UHFFFAOYSA-N Pseudouridine C Natural products OC1C(O)C(CO)OC1C1=CNC(=O)NC1=O PTJWIQPHWPFNBW-UHFFFAOYSA-N 0.000 description 2
• 102000014450 RNA Polymerase III Human genes 0.000 description 2
• 108010078067 RNA Polymerase III Proteins 0.000 description 2
• 239000012980 RPMI-1640 medium Substances 0.000 description 2
• 206010038389 Renal cancer Diseases 0.000 description 2
• 239000006146 Roswell Park Memorial Institute medium Substances 0.000 description 2
• 101001037255 Saccharomyces cerevisiae (strain ATCC 204508 / S288c) Indoleamine 2,3-dioxygenase Proteins 0.000 description 2
• MTCFGRXMJLQNBG-UHFFFAOYSA-N Serine Natural products OCC(N)C(O)=O MTCFGRXMJLQNBG-UHFFFAOYSA-N 0.000 description 2
• 108010052160 Site-specific recombinase Proteins 0.000 description 2
• 108091027967 Small hairpin RNA Proteins 0.000 description 2
• 208000005718 Stomach Neoplasms Diseases 0.000 description 2
• 101100215487 Sus scrofa ADRA2A gene Proteins 0.000 description 2
• 101000987219 Sus scrofa Pregnancy-associated glycoprotein 1 Proteins 0.000 description 2
• 230000005867 T cell response Effects 0.000 description 2
• 229940126547 T-cell immunoglobulin mucin-3 Drugs 0.000 description 2
• 108091007178 TNFRSF10A Proteins 0.000 description 2
• 208000024770 Thyroid neoplasm Diseases 0.000 description 2
• 102000040945 Transcription factor Human genes 0.000 description 2
• 102100030742 Transforming growth factor beta-1 proprotein Human genes 0.000 description 2
• GLNADSQYFUSGOU-GPTZEZBUSA-J Trypan blue Chemical compound [Na+].[Na+].[Na+].[Na+].C1=C(S([O-])(=O)=O)C=C2C=C(S([O-])(=O)=O)C(/N=N/C3=CC=C(C=C3C)C=3C=C(C(=CC=3)\N=N\C=3C(=CC4=CC(=CC(N)=C4C=3O)S([O-])(=O)=O)S([O-])(=O)=O)C)=C(O)C2=C1N GLNADSQYFUSGOU-GPTZEZBUSA-J 0.000 description 2
• 102100032101 Tumor necrosis factor ligand superfamily member 9 Human genes 0.000 description 2
• 102100040113 Tumor necrosis factor receptor superfamily member 10A Human genes 0.000 description 2
• 102100033728 Tumor necrosis factor receptor superfamily member 18 Human genes 0.000 description 2
• 102100040245 Tumor necrosis factor receptor superfamily member 5 Human genes 0.000 description 2
• 108020005202 Viral DNA Proteins 0.000 description 2
• 101710124907 X-ray repair cross-complementing protein 6 Proteins 0.000 description 2
• YIJVOACVHQZMKI-JXOAFFINSA-N [[(2r,3s,4r,5r)-5-(4-amino-5-methyl-2-oxopyrimidin-1-yl)-3,4-dihydroxyoxolan-2-yl]methoxy-hydroxyphosphoryl] phosphono hydrogen phosphate Chemical compound O=C1N=C(N)C(C)=CN1[C@H]1[C@H](O)[C@H](O)[C@@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)O1 YIJVOACVHQZMKI-JXOAFFINSA-N 0.000 description 2
• 230000002159 abnormal effect Effects 0.000 description 2
• 239000002253 acid Substances 0.000 description 2
• DZBUGLKDJFMEHC-UHFFFAOYSA-N acridine Chemical compound C1=CC=CC2=CC3=CC=CC=C3N=C21 DZBUGLKDJFMEHC-UHFFFAOYSA-N 0.000 description 2
• 239000000654 additive Substances 0.000 description 2
• OFHCOWSQAMBJIW-AVJTYSNKSA-N alfacalcidol Chemical group C1(/[C@@H]2CC[C@@H]([C@]2(CCC1)C)[C@H](C)CCCC(C)C)=C\C=C1\C[C@@H](O)C[C@H](O)C1=C OFHCOWSQAMBJIW-AVJTYSNKSA-N 0.000 description 2
• 125000003275 alpha amino acid group Chemical group 0.000 description 2
• 229940024606 amino acid Drugs 0.000 description 2
• 235000001014 amino acid Nutrition 0.000 description 2
• 150000001413 amino acids Chemical class 0.000 description 2
• 230000006399 behavior Effects 0.000 description 2
• WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 2
• WGDUUQDYDIIBKT-UHFFFAOYSA-N beta-Pseudouridine Natural products OC1OC(CN2C=CC(=O)NC2=O)C(O)C1O WGDUUQDYDIIBKT-UHFFFAOYSA-N 0.000 description 2
• 230000004071 biological effect Effects 0.000 description 2
• 230000008827 biological function Effects 0.000 description 2
• 230000015556 catabolic process Effects 0.000 description 2
• 238000004113 cell culture Methods 0.000 description 2
• 230000024245 cell differentiation Effects 0.000 description 2
• 210000000170 cell membrane Anatomy 0.000 description 2
• 108010072917 class-I restricted T cell-associated molecule Proteins 0.000 description 2
• 238000002648 combination therapy Methods 0.000 description 2
• 239000002131 composite material Substances 0.000 description 2
• 210000001151 cytotoxic T lymphocyte Anatomy 0.000 description 2
• 238000000354 decomposition reaction Methods 0.000 description 2
• 238000006731 degradation reaction Methods 0.000 description 2
• 238000000326 densiometry Methods 0.000 description 2
• 238000001514 detection method Methods 0.000 description 2
• 230000004069 differentiation Effects 0.000 description 2
• 238000007847 digital PCR Methods 0.000 description 2
• LOKCTEFSRHRXRJ-UHFFFAOYSA-I dipotassium trisodium dihydrogen phosphate hydrogen phosphate dichloride Chemical compound P(=O)(O)(O)[O-].[K+].P(=O)(O)([O-])[O-].[Na+].[Na+].[Cl-].[K+].[Cl-].[Na+] LOKCTEFSRHRXRJ-UHFFFAOYSA-I 0.000 description 2
• 108010030074 endodeoxyribonuclease MluI Proteins 0.000 description 2
• 238000005516 engineering process Methods 0.000 description 2
• 201000004101 esophageal cancer Diseases 0.000 description 2
• 150000002148 esters Chemical class 0.000 description 2
• 210000003527 eukaryotic cell Anatomy 0.000 description 2
• 230000001747 exhibiting effect Effects 0.000 description 2
• 238000002474 experimental method Methods 0.000 description 2
• 238000000278 gas antisolvent technique Methods 0.000 description 2
• 206010017758 gastric cancer Diseases 0.000 description 2
• 238000010363 gene targeting Methods 0.000 description 2
• 238000004128 high performance liquid chromatography Methods 0.000 description 2
• 102000027596 immune receptors Human genes 0.000 description 2
• 108091008915 immune receptors Proteins 0.000 description 2
• 230000006872 improvement Effects 0.000 description 2
• 238000010348 incorporation Methods 0.000 description 2
• 210000004263 induced pluripotent stem cell Anatomy 0.000 description 2
• 108091008042 inhibitory receptors Proteins 0.000 description 2
• NOESYZHRGYRDHS-UHFFFAOYSA-N insulin Chemical compound N1C(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(NC(=O)CN)C(C)CC)CSSCC(C(NC(CO)C(=O)NC(CC(C)C)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CCC(N)=O)C(=O)NC(CC(C)C)C(=O)NC(CCC(O)=O)C(=O)NC(CC(N)=O)C(=O)NC(CC=2C=CC(O)=CC=2)C(=O)NC(CSSCC(NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2C=CC(O)=CC=2)NC(=O)C(CC(C)C)NC(=O)C(C)NC(=O)C(CCC(O)=O)NC(=O)C(C(C)C)NC(=O)C(CC(C)C)NC(=O)C(CC=2NC=NC=2)NC(=O)C(CO)NC(=O)CNC2=O)C(=O)NCC(=O)NC(CCC(O)=O)C(=O)NC(CCCNC(N)=N)C(=O)NCC(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC=CC=3)C(=O)NC(CC=3C=CC(O)=CC=3)C(=O)NC(C(C)O)C(=O)N3C(CCC3)C(=O)NC(CCCCN)C(=O)NC(C)C(O)=O)C(=O)NC(CC(N)=O)C(O)=O)=O)NC(=O)C(C(C)CC)NC(=O)C(CO)NC(=O)C(C(C)O)NC(=O)C1CSSCC2NC(=O)C(CC(C)C)NC(=O)C(NC(=O)C(CCC(N)=O)NC(=O)C(CC(N)=O)NC(=O)C(NC(=O)C(N)CC=1C=CC=CC=1)C(C)C)CC1=CN=CN1 NOESYZHRGYRDHS-UHFFFAOYSA-N 0.000 description 2
• 108010052790 interleukin 1 precursor Proteins 0.000 description 2
• 229940100601 interleukin-6 Drugs 0.000 description 2
• 201000010982 kidney cancer Diseases 0.000 description 2
• 210000004901 leucine-rich repeat Anatomy 0.000 description 2
• 208000032839 leukemia Diseases 0.000 description 2
• 239000002502 liposome Substances 0.000 description 2
• 201000007270 liver cancer Diseases 0.000 description 2
• 208000014018 liver neoplasm Diseases 0.000 description 2
• 230000004807 localization Effects 0.000 description 2
• 201000005202 lung cancer Diseases 0.000 description 2
• 208000020816 lung neoplasm Diseases 0.000 description 2
• 239000003550 marker Substances 0.000 description 2
• 230000007246 mechanism Effects 0.000 description 2
• 201000001441 melanoma Diseases 0.000 description 2
• 208000037819 metastatic cancer Diseases 0.000 description 2
• 208000011575 metastatic malignant neoplasm Diseases 0.000 description 2
• 239000011859 microparticle Substances 0.000 description 2
• 239000007758 minimum essential medium Substances 0.000 description 2
• 210000001616 monocyte Anatomy 0.000 description 2
• 230000030147 nuclear export Effects 0.000 description 2
• 210000000056 organ Anatomy 0.000 description 2
• 230000005298 paramagnetic effect Effects 0.000 description 2
• 238000002823 phage display Methods 0.000 description 2
• NBIIXXVUZAFLBC-UHFFFAOYSA-K phosphate Chemical compound [O-]P([O-])([O-])=O NBIIXXVUZAFLBC-UHFFFAOYSA-K 0.000 description 2
• 239000010452 phosphate Substances 0.000 description 2
• 239000002953 phosphate buffered saline Substances 0.000 description 2
• 150000004713 phosphodiesters Chemical class 0.000 description 2
• 230000035479 physiological effects, processes and functions Effects 0.000 description 2
• 229920001223 polyethylene glycol Polymers 0.000 description 2
• 229920002223 polystyrene Polymers 0.000 description 2
• 239000002243 precursor Substances 0.000 description 2
• 238000002360 preparation method Methods 0.000 description 2
• 230000000770 proinflammatory effect Effects 0.000 description 2
• PTJWIQPHWPFNBW-GBNDHIKLSA-N pseudouridine Chemical group O[C@@H]1[C@H](O)[C@@H](CO)O[C@H]1C1=CNC(=O)NC1=O PTJWIQPHWPFNBW-GBNDHIKLSA-N 0.000 description 2
• 238000003908 quality control method Methods 0.000 description 2
• 230000008707 rearrangement Effects 0.000 description 2
• 108091008146 restriction endonucleases Proteins 0.000 description 2
• 230000001177 retroviral effect Effects 0.000 description 2
• 238000010839 reverse transcription Methods 0.000 description 2
• 210000003705 ribosome Anatomy 0.000 description 2
• 239000004055 small Interfering RNA Substances 0.000 description 2
• DAEPDZWVDSPTHF-UHFFFAOYSA-M sodium pyruvate Chemical compound [Na+].CC(=O)C([O-])=O DAEPDZWVDSPTHF-UHFFFAOYSA-M 0.000 description 2
• 239000000243 solution Substances 0.000 description 2
• 201000011549 stomach cancer Diseases 0.000 description 2
• UCSJYZPVAKXKNQ-HZYVHMACSA-N streptomycin Chemical compound CN[C@H]1[C@H](O)[C@@H](O)[C@H](CO)O[C@H]1O[C@@H]1[C@](C=O)(O)[C@H](C)O[C@H]1O[C@@H]1[C@@H](NC(N)=N)[C@H](O)[C@@H](NC(N)=N)[C@H](O)[C@H]1O UCSJYZPVAKXKNQ-HZYVHMACSA-N 0.000 description 2
• 238000006467 substitution reaction Methods 0.000 description 2
• 238000003786 synthesis reaction Methods 0.000 description 2
• 108091035539 telomere Proteins 0.000 description 2
• 102000055501 telomere Human genes 0.000 description 2
• 210000003411 telomere Anatomy 0.000 description 2
• 201000002510 thyroid cancer Diseases 0.000 description 2
• 230000002103 transcriptional effect Effects 0.000 description 2
• 238000002054 transplantation Methods 0.000 description 2
• 239000001226 triphosphate Substances 0.000 description 2
• 210000004881 tumor cell Anatomy 0.000 description 2
• 238000001262 western blot Methods 0.000 description 2
• DGVVWUTYPXICAM-UHFFFAOYSA-N β‐Mercaptoethanol Chemical compound OCCS DGVVWUTYPXICAM-UHFFFAOYSA-N 0.000 description 2
• AUTOLBMXDDTRRT-JGVFFNPUSA-N (4R,5S)-dethiobiotin Chemical compound C[C@@H]1NC(=O)N[C@@H]1CCCCCC(O)=O AUTOLBMXDDTRRT-JGVFFNPUSA-N 0.000 description 1
• FQVLRGLGWNWPSS-BXBUPLCLSA-N (4r,7s,10s,13s,16r)-16-acetamido-13-(1h-imidazol-5-ylmethyl)-10-methyl-6,9,12,15-tetraoxo-7-propan-2-yl-1,2-dithia-5,8,11,14-tetrazacycloheptadecane-4-carboxamide Chemical compound N1C(=O)[C@@H](NC(C)=O)CSSC[C@@H](C(N)=O)NC(=O)[C@H](C(C)C)NC(=O)[C@H](C)NC(=O)[C@@H]1CC1=CN=CN1 FQVLRGLGWNWPSS-BXBUPLCLSA-N 0.000 description 1
• WCKQPPQRFNHPRJ-UHFFFAOYSA-N 4-[[4-(dimethylamino)phenyl]diazenyl]benzoic acid Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(O)=O)C=C1 WCKQPPQRFNHPRJ-UHFFFAOYSA-N 0.000 description 1
• HWRFTOWHSBECMR-UHFFFAOYSA-N 6-n-[(4-aminophenyl)methyl]-2-n-[[3-(trifluoromethyl)phenyl]methyl]-7h-purine-2,6-diamine Chemical class C1=CC(N)=CC=C1CNC1=NC(NCC=2C=C(C=CC=2)C(F)(F)F)=NC2=C1NC=N2 HWRFTOWHSBECMR-UHFFFAOYSA-N 0.000 description 1
• FHVDTGUDJYJELY-UHFFFAOYSA-N 6-{[2-carboxy-4,5-dihydroxy-6-(phosphanyloxy)oxan-3-yl]oxy}-4,5-dihydroxy-3-phosphanyloxane-2-carboxylic acid Chemical compound O1C(C(O)=O)C(P)C(O)C(O)C1OC1C(C(O)=O)OC(OP)C(O)C1O FHVDTGUDJYJELY-UHFFFAOYSA-N 0.000 description 1
• 208000035657 Abasia Diseases 0.000 description 1
• QTBSBXVTEAMEQO-UHFFFAOYSA-M Acetate Chemical compound CC([O-])=O QTBSBXVTEAMEQO-UHFFFAOYSA-M 0.000 description 1
• 208000031261 Acute myeloid leukaemia Diseases 0.000 description 1
• 101100524317 Adeno-associated virus 2 (isolate Srivastava/1982) Rep40 gene Proteins 0.000 description 1
• 101100524319 Adeno-associated virus 2 (isolate Srivastava/1982) Rep52 gene Proteins 0.000 description 1
• 101100524321 Adeno-associated virus 2 (isolate Srivastava/1982) Rep68 gene Proteins 0.000 description 1
• 101100524324 Adeno-associated virus 2 (isolate Srivastava/1982) Rep78 gene Proteins 0.000 description 1
• 102100034035 Alcohol dehydrogenase 1A Human genes 0.000 description 1
• GUBGYTABKSRVRQ-XLOQQCSPSA-N Alpha-Lactose Chemical compound O[C@@H]1[C@@H](O)[C@@H](O)[C@@H](CO)O[C@H]1O[C@@H]1[C@@H](CO)O[C@H](O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-XLOQQCSPSA-N 0.000 description 1
• QGZKDVFQNNGYKY-UHFFFAOYSA-O Ammonium Chemical compound [NH4+] QGZKDVFQNNGYKY-UHFFFAOYSA-O 0.000 description 1
• 208000007860 Anus Neoplasms Diseases 0.000 description 1
• 241001244729 Apalis Species 0.000 description 1
• 206010003445 Ascites Diseases 0.000 description 1
• 102000002804 Ataxia Telangiectasia Mutated Proteins Human genes 0.000 description 1
• 208000010839 B-cell chronic lymphocytic leukemia Diseases 0.000 description 1
• 241000283690 Bos taurus Species 0.000 description 1
• 108010084313 CD58 Antigens Proteins 0.000 description 1
• 102100025221 CD70 antigen Human genes 0.000 description 1
• 101150043532 CISH gene Proteins 0.000 description 1
• 238000010356 CRISPR-Cas9 genome editing Methods 0.000 description 1
• 101150018129 CSF2 gene Proteins 0.000 description 1
• 101150069031 CSN2 gene Proteins 0.000 description 1
• OYPRJOBELJOOCE-UHFFFAOYSA-N Calcium Chemical compound [Ca] OYPRJOBELJOOCE-UHFFFAOYSA-N 0.000 description 1
• 102000004657 Calcium-Calmodulin-Dependent Protein Kinase Type 2 Human genes 0.000 description 1
• 108010003721 Calcium-Calmodulin-Dependent Protein Kinase Type 2 Proteins 0.000 description 1
• 108090000565 Capsid Proteins Proteins 0.000 description 1
• OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 1
• 206010007279 Carcinoid tumour of the gastrointestinal tract Diseases 0.000 description 1
• 201000009030 Carcinoma Diseases 0.000 description 1
• 108090000994 Catalytic RNA Proteins 0.000 description 1
• 102000053642 Catalytic RNA Human genes 0.000 description 1
• 102100023321 Ceruloplasmin Human genes 0.000 description 1
• 206010008342 Cervix carcinoma Diseases 0.000 description 1
• 229920001661 Chitosan Polymers 0.000 description 1
• 108010077544 Chromatin Proteins 0.000 description 1
• 108020004705 Codon Proteins 0.000 description 1
• 108010035532 Collagen Proteins 0.000 description 1
• 102000008186 Collagen Human genes 0.000 description 1
• 108091035707 Consensus sequence Proteins 0.000 description 1
• 108010069514 Cyclic Peptides Proteins 0.000 description 1
• 102000001189 Cyclic Peptides Human genes 0.000 description 1
• FBPFZTCFMRRESA-FSIIMWSLSA-N D-Glucitol Natural products OC[C@H](O)[C@H](O)[C@@H](O)[C@H](O)CO FBPFZTCFMRRESA-FSIIMWSLSA-N 0.000 description 1
• FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 1
• FBPFZTCFMRRESA-JGWLITMVSA-N D-glucitol Chemical compound OC[C@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-JGWLITMVSA-N 0.000 description 1
• MNQZXJOMYWMBOU-VKHMYHEASA-N D-glyceraldehyde Chemical compound OC[C@@H](O)C=O MNQZXJOMYWMBOU-VKHMYHEASA-N 0.000 description 1
• WQZGKKKJIJFFOK-QTVWNMPRSA-N D-mannopyranose Chemical compound OC[C@H]1OC(O)[C@@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-QTVWNMPRSA-N 0.000 description 1
• 230000004543 DNA replication Effects 0.000 description 1
• 108010014303 DNA-directed DNA polymerase Proteins 0.000 description 1
• 102000016928 DNA-directed DNA polymerase Human genes 0.000 description 1
• 108090000626 DNA-directed RNA polymerases Proteins 0.000 description 1
• 102000004163 DNA-directed RNA polymerases Human genes 0.000 description 1
• 101710088194 Dehydrogenase Proteins 0.000 description 1
• 229920002307 Dextran Polymers 0.000 description 1
• 239000006144 Dulbecco’s modified Eagle's medium Substances 0.000 description 1
• 101710091045 Envelope protein Proteins 0.000 description 1
• 241000702055 Escherichia virus HK022 Species 0.000 description 1
• 201000008808 Fibrosarcoma Diseases 0.000 description 1
• 102100035233 Furin Human genes 0.000 description 1
• 108090001126 Furin Proteins 0.000 description 1
• 102100024637 Galectin-10 Human genes 0.000 description 1
• 208000022072 Gallbladder Neoplasms Diseases 0.000 description 1
• 101001011019 Gallus gallus Gallinacin-10 Proteins 0.000 description 1
• 101001011021 Gallus gallus Gallinacin-12 Proteins 0.000 description 1
• 206010017993 Gastrointestinal neoplasms Diseases 0.000 description 1
• 108010010803 Gelatin Proteins 0.000 description 1
• 108700039691 Genetic Promoter Regions Proteins 0.000 description 1
• 101000892220 Geobacillus thermodenitrificans (strain NG80-2) Long-chain-alcohol dehydrogenase 1 Proteins 0.000 description 1
• 108091093094 Glycol nucleic acid Proteins 0.000 description 1
• 108010017213 Granulocyte-Macrophage Colony-Stimulating Factor Proteins 0.000 description 1
• 102100039620 Granulocyte-macrophage colony-stimulating factor Human genes 0.000 description 1
• 102100030385 Granzyme B Human genes 0.000 description 1
• NYHBQMYGNKIUIF-UUOKFMHZSA-N Guanosine Chemical class C1=NC=2C(=O)NC(N)=NC=2N1[C@@H]1O[C@H](CO)[C@@H](O)[C@H]1O NYHBQMYGNKIUIF-UUOKFMHZSA-N 0.000 description 1
• XKMLYUALXHKNFT-UUOKFMHZSA-N Guanosine-5'-triphosphate Chemical compound C1=2NC(N)=NC(=O)C=2N=CN1[C@@H]1O[C@H](COP(O)(=O)OP(O)(=O)OP(O)(O)=O)[C@@H](O)[C@H]1O XKMLYUALXHKNFT-UUOKFMHZSA-N 0.000 description 1
• 102100028972 HLA class I histocompatibility antigen, A alpha chain Human genes 0.000 description 1
• 108010075704 HLA-A Antigens Proteins 0.000 description 1
• 102000009485 HLA-D Antigens Human genes 0.000 description 1
• 108010048896 HLA-D Antigens Proteins 0.000 description 1
• 208000002250 Hematologic Neoplasms Diseases 0.000 description 1
• 241000700739 Hepadnaviridae Species 0.000 description 1
• 241000700721 Hepatitis B virus Species 0.000 description 1
• 108091027305 Heteroduplex Proteins 0.000 description 1
• 102100026122 High affinity immunoglobulin gamma Fc receptor I Human genes 0.000 description 1
• 241000282412 Homo Species 0.000 description 1
• 101000756632 Homo sapiens Actin, cytoplasmic 1 Proteins 0.000 description 1
• 101000780443 Homo sapiens Alcohol dehydrogenase 1A Proteins 0.000 description 1
• 101000834898 Homo sapiens Alpha-synuclein Proteins 0.000 description 1
• 101000934356 Homo sapiens CD70 antigen Proteins 0.000 description 1
• 101001015963 Homo sapiens E3 ubiquitin-protein ligase Mdm2 Proteins 0.000 description 1
• 101001009603 Homo sapiens Granzyme B Proteins 0.000 description 1
• 101000913074 Homo sapiens High affinity immunoglobulin gamma Fc receptor I Proteins 0.000 description 1
• 101001019455 Homo sapiens ICOS ligand Proteins 0.000 description 1
• 101001055145 Homo sapiens Interleukin-2 receptor subunit beta Proteins 0.000 description 1
• 101000917826 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-a Proteins 0.000 description 1
• 101000917824 Homo sapiens Low affinity immunoglobulin gamma Fc region receptor II-b Proteins 0.000 description 1
• 101000578784 Homo sapiens Melanoma antigen recognized by T-cells 1 Proteins 0.000 description 1
• 101100298247 Homo sapiens PPP1R12C gene Proteins 0.000 description 1
• 101000652359 Homo sapiens Spermatogenesis-associated protein 2 Proteins 0.000 description 1
• 101000763579 Homo sapiens Toll-like receptor 1 Proteins 0.000 description 1
• 101000611183 Homo sapiens Tumor necrosis factor Proteins 0.000 description 1
• 101000767629 Human papillomavirus type 18 Protein E7 Proteins 0.000 description 1
• 102100034980 ICOS ligand Human genes 0.000 description 1
• 102000053646 Inducible T-Cell Co-Stimulator Human genes 0.000 description 1
• 108700013161 Inducible T-Cell Co-Stimulator Proteins 0.000 description 1
• 102000004877 Insulin Human genes 0.000 description 1
• 108090001061 Insulin Proteins 0.000 description 1
• 102100034349 Integrase Human genes 0.000 description 1
• 101710203526 Integrase Proteins 0.000 description 1
• 108010064593 Intercellular Adhesion Molecule-1 Proteins 0.000 description 1
• 102100037877 Intercellular adhesion molecule 1 Human genes 0.000 description 1
• 102000003996 Interferon-beta Human genes 0.000 description 1
• 108090000467 Interferon-beta Proteins 0.000 description 1
• 102000003814 Interleukin-10 Human genes 0.000 description 1
• 108090000174 Interleukin-10 Proteins 0.000 description 1
• 108010065805 Interleukin-12 Proteins 0.000 description 1
• 102000013462 Interleukin-12 Human genes 0.000 description 1
• 102000013691 Interleukin-17 Human genes 0.000 description 1
• 108050003558 Interleukin-17 Proteins 0.000 description 1
• 102100026879 Interleukin-2 receptor subunit beta Human genes 0.000 description 1
• 108090000978 Interleukin-4 Proteins 0.000 description 1
• 102000004388 Interleukin-4 Human genes 0.000 description 1
• 108091092195 Intron Proteins 0.000 description 1
• PWKSKIMOESPYIA-BYPYZUCNSA-N L-N-acetyl-Cysteine Chemical compound CC(=O)N[C@@H](CS)C(O)=O PWKSKIMOESPYIA-BYPYZUCNSA-N 0.000 description 1
• OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 1
• GUBGYTABKSRVRQ-QKKXKWKRSA-N Lactose Natural products OC[C@H]1O[C@@H](O[C@H]2[C@H](O)[C@@H](O)C(O)O[C@@H]2CO)[C@H](O)[C@@H](O)[C@H]1O GUBGYTABKSRVRQ-QKKXKWKRSA-N 0.000 description 1
• 206010023825 Laryngeal cancer Diseases 0.000 description 1
• 206010024291 Leukaemias acute myeloid Diseases 0.000 description 1
• 102100029204 Low affinity immunoglobulin gamma Fc region receptor II-a Human genes 0.000 description 1
• 208000031422 Lymphocytic Chronic B-Cell Leukemia Diseases 0.000 description 1
• 241000829100 Macaca mulatta polyomavirus 1 Species 0.000 description 1
• FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
• 229930195725 Mannitol Natural products 0.000 description 1
• 102100028389 Melanoma antigen recognized by T-cells 1 Human genes 0.000 description 1
• 206010027476 Metastases Diseases 0.000 description 1
• 108700011259 MicroRNAs Proteins 0.000 description 1
• 102000029749 Microtubule Human genes 0.000 description 1
• 108091022875 Microtubule Proteins 0.000 description 1
• 101710145242 Minor capsid protein P3-RTD Proteins 0.000 description 1
• 241000713869 Moloney murine leukemia virus Species 0.000 description 1
• 208000034578 Multiple myelomas Diseases 0.000 description 1
• 241000714177 Murine leukemia virus Species 0.000 description 1
• 241000699660 Mus musculus Species 0.000 description 1
• 101001009604 Mus musculus Granzyme B(G,H) Proteins 0.000 description 1
• 101100508818 Mus musculus Inpp5k gene Proteins 0.000 description 1
• 101100494762 Mus musculus Nedd9 gene Proteins 0.000 description 1
• 101100298248 Mus musculus Ppp1r12c gene Proteins 0.000 description 1
• 208000033776 Myeloid Acute Leukemia Diseases 0.000 description 1
• 241000713883 Myeloproliferative sarcoma virus Species 0.000 description 1
• 206010028729 Nasal cavity cancer Diseases 0.000 description 1
• 208000001894 Nasopharyngeal Neoplasms Diseases 0.000 description 1
• 208000009869 Neu-Laxova syndrome Diseases 0.000 description 1
• 101100385413 Neurospora crassa (strain ATCC 24698 / 74-OR23-1A / CBS 708.71 / DSM 1257 / FGSC 987) csm-3 gene Proteins 0.000 description 1
• 208000015914 Non-Hodgkin lymphomas Diseases 0.000 description 1
• 101710144111 Non-structural protein 3 Proteins 0.000 description 1
• 108091092724 Noncoding DNA Proteins 0.000 description 1
• 208000010505 Nose Neoplasms Diseases 0.000 description 1
• 101150035493 PPP1R12C gene Proteins 0.000 description 1
• 108020002230 Pancreatic Ribonuclease Proteins 0.000 description 1
• 206010061902 Pancreatic neoplasm Diseases 0.000 description 1
• 102000005891 Pancreatic ribonuclease Human genes 0.000 description 1
• 229930182555 Penicillin Natural products 0.000 description 1
• JGSARLDLIJGVTE-MBNYWOFBSA-N Penicillin G Chemical compound N([C@H]1[C@H]2SC([C@@H](N2C1=O)C(O)=O)(C)C)C(=O)CC1=CC=CC=C1 JGSARLDLIJGVTE-MBNYWOFBSA-N 0.000 description 1
• 102000035195 Peptidases Human genes 0.000 description 1
• 108091005804 Peptidases Proteins 0.000 description 1
• 108091093037 Peptide nucleic acid Proteins 0.000 description 1
• 208000009565 Pharyngeal Neoplasms Diseases 0.000 description 1
• 208000002151 Pleural effusion Diseases 0.000 description 1
• 102100037935 Polyubiquitin-C Human genes 0.000 description 1
• 239000004365 Protease Substances 0.000 description 1
• 102000003923 Protein Kinase C Human genes 0.000 description 1
• 108090000315 Protein Kinase C Proteins 0.000 description 1
• 101710150344 Protein Rev Proteins 0.000 description 1
• CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 1
• MTVVRWVOXZSVBW-UHFFFAOYSA-M QSY21 succinimidyl ester Chemical compound [Cl-].C1CN(S(=O)(=O)C=2C(=CC=CC=2)C2=C3C=CC(C=C3OC3=CC(=CC=C32)N2CC3=CC=CC=C3C2)=[N+]2CC3=CC=CC=C3C2)CCC1C(=O)ON1C(=O)CCC1=O MTVVRWVOXZSVBW-UHFFFAOYSA-M 0.000 description 1
• GMRIOMQGYOXUCH-UHFFFAOYSA-N QSY35 succinimidyl ester Chemical compound C12=NON=C2C([N+](=O)[O-])=CC=C1NC(C=C1)=CC=C1CC(=O)ON1C(=O)CCC1=O GMRIOMQGYOXUCH-UHFFFAOYSA-N 0.000 description 1
• BDJDTKYGKHEMFF-UHFFFAOYSA-M QSY7 succinimidyl ester Chemical compound [Cl-].C=1C=C2C(C=3C(=CC=CC=3)S(=O)(=O)N3CCC(CC3)C(=O)ON3C(CCC3=O)=O)=C3C=C\C(=[N+](\C)C=4C=CC=CC=4)C=C3OC2=CC=1N(C)C1=CC=CC=C1 BDJDTKYGKHEMFF-UHFFFAOYSA-M 0.000 description 1
• PAOKYIAFAJVBKU-UHFFFAOYSA-N QSY9 succinimidyl ester Chemical compound [H+].[H+].[Cl-].C=1C=C2C(C=3C(=CC=CC=3)S(=O)(=O)N3CCC(CC3)C(=O)ON3C(CCC3=O)=O)=C3C=C\C(=[N+](\C)C=4C=CC(=CC=4)S([O-])(=O)=O)C=C3OC2=CC=1N(C)C1=CC=C(S([O-])(=O)=O)C=C1 PAOKYIAFAJVBKU-UHFFFAOYSA-N 0.000 description 1
• 102000009572 RNA Polymerase II Human genes 0.000 description 1
• 108010009460 RNA Polymerase II Proteins 0.000 description 1
• 230000026279 RNA modification Effects 0.000 description 1
• 230000006819 RNA synthesis Effects 0.000 description 1
• 230000004570 RNA-binding Effects 0.000 description 1
• 238000011529 RT qPCR Methods 0.000 description 1
• 208000037323 Rare tumor Diseases 0.000 description 1
• 101100173636 Rattus norvegicus Fhl2 gene Proteins 0.000 description 1
• 101100366438 Rattus norvegicus Sphkap gene Proteins 0.000 description 1
• 208000015634 Rectal Neoplasms Diseases 0.000 description 1
• 241001492360 Retroviral provirus Species 0.000 description 1
• 108091028664 Ribonucleotide Proteins 0.000 description 1
• 101100010928 Saccharolobus solfataricus (strain ATCC 35092 / DSM 1617 / JCM 11322 / P2) tuf gene Proteins 0.000 description 1
• 206010039491 Sarcoma Diseases 0.000 description 1
• 208000000453 Skin Neoplasms Diseases 0.000 description 1
• 108020004459 Small interfering RNA Proteins 0.000 description 1
• FAPWRFPIFSIZLT-UHFFFAOYSA-M Sodium chloride Chemical compound [Na+].[Cl-] FAPWRFPIFSIZLT-UHFFFAOYSA-M 0.000 description 1
• 208000032383 Soft tissue cancer Diseases 0.000 description 1
• 229920002125 Sokalan® Polymers 0.000 description 1
• 229920002472 Starch Polymers 0.000 description 1
• 241000187747 Streptomyces Species 0.000 description 1
• 241000702031 Streptomyces phage R4 Species 0.000 description 1
• 101710172711 Structural protein Proteins 0.000 description 1
• 229930006000 Sucrose Natural products 0.000 description 1
• CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
• 101150001810 TEAD1 gene Proteins 0.000 description 1
• 101150074253 TEF1 gene Proteins 0.000 description 1
• 108010017842 Telomerase Proteins 0.000 description 1
• 208000024313 Testicular Neoplasms Diseases 0.000 description 1
• 206010057644 Testis cancer Diseases 0.000 description 1
• 239000004098 Tetracycline Substances 0.000 description 1
• WDLRUFUQRNWCPK-UHFFFAOYSA-N Tetraxetan Chemical compound OC(=O)CN1CCN(CC(O)=O)CCN(CC(O)=O)CCN(CC(O)=O)CC1 WDLRUFUQRNWCPK-UHFFFAOYSA-N 0.000 description 1
• 108091046915 Threose nucleic acid Proteins 0.000 description 1
• 102100029898 Transcriptional enhancer factor TEF-1 Human genes 0.000 description 1
• 102100040247 Tumor necrosis factor Human genes 0.000 description 1
• 102100022153 Tumor necrosis factor receptor superfamily member 4 Human genes 0.000 description 1
• 101710165473 Tumor necrosis factor receptor superfamily member 4 Proteins 0.000 description 1
• 108010056354 Ubiquitin C Proteins 0.000 description 1
• 208000023915 Ureteral Neoplasms Diseases 0.000 description 1
• 206010046392 Ureteric cancer Diseases 0.000 description 1
• 208000006105 Uterine Cervical Neoplasms Diseases 0.000 description 1
• 108700005077 Viral Genes Proteins 0.000 description 1
• 208000004354 Vulvar Neoplasms Diseases 0.000 description 1
• 241001492404 Woodchuck hepatitis virus Species 0.000 description 1
• 208000027418 Wounds and injury Diseases 0.000 description 1
• 229960004308 acetylcysteine Drugs 0.000 description 1
• 230000001154 acute effect Effects 0.000 description 1
• UDMBCSSLTHHNCD-KQYNXXCUSA-N adenosine 5'-monophosphate Chemical compound C1=NC=2C(N)=NC=NC=2N1[C@@H]1O[C@H](COP(O)(O)=O)[C@@H](O)[C@H]1O UDMBCSSLTHHNCD-KQYNXXCUSA-N 0.000 description 1
• 230000001270 agonistic effect Effects 0.000 description 1
• 229940072056 alginate Drugs 0.000 description 1
• 235000010443 alginic acid Nutrition 0.000 description 1
• 229920000615 alginic acid Polymers 0.000 description 1
• 230000029936 alkylation Effects 0.000 description 1
• 238000005804 alkylation reaction Methods 0.000 description 1
• 238000011316 allogeneic transplantation Methods 0.000 description 1
• 206010065867 alveolar rhabdomyosarcoma Diseases 0.000 description 1
• 230000009435 amidation Effects 0.000 description 1
• 238000007112 amidation reaction Methods 0.000 description 1
• 230000003321 amplification Effects 0.000 description 1
• 210000002255 anal canal Anatomy 0.000 description 1
• 238000004873 anchoring Methods 0.000 description 1
• 238000000137 annealing Methods 0.000 description 1
• 239000003242 anti bacterial agent Substances 0.000 description 1
• 230000001093 anti-cancer Effects 0.000 description 1
• 230000000692 anti-sense effect Effects 0.000 description 1
• 229940088710 antibiotic agent Drugs 0.000 description 1
• 230000005875 antibody response Effects 0.000 description 1
• 230000030741 antigen processing and presentation Effects 0.000 description 1
• 239000002246 antineoplastic agent Substances 0.000 description 1
• 238000003782 apoptosis assay Methods 0.000 description 1
• 239000012298 atmosphere Substances 0.000 description 1
• 230000004900 autophagic degradation Effects 0.000 description 1
• DMLAVOWQYNRWNQ-UHFFFAOYSA-N azobenzene Chemical compound C1=CC=CC=C1N=NC1=CC=CC=C1 DMLAVOWQYNRWNQ-UHFFFAOYSA-N 0.000 description 1
• 230000003115 biocidal effect Effects 0.000 description 1
• 238000001815 biotherapy Methods 0.000 description 1
• 230000006287 biotinylation Effects 0.000 description 1
• 238000007413 biotinylation Methods 0.000 description 1
• 210000001185 bone marrow Anatomy 0.000 description 1
• 210000000481 breast Anatomy 0.000 description 1
• 229960005520 bryostatin Drugs 0.000 description 1
• MJQUEDHRCUIRLF-TVIXENOKSA-N bryostatin 1 Chemical compound C([C@@H]1CC(/[C@@H]([C@@](C(C)(C)/C=C/2)(O)O1)OC(=O)/C=C/C=C/CCC)=C\C(=O)OC)[C@H]([C@@H](C)O)OC(=O)C[C@H](O)C[C@@H](O1)C[C@H](OC(C)=O)C(C)(C)[C@]1(O)C[C@@H]1C\C(=C\C(=O)OC)C[C@H]\2O1 MJQUEDHRCUIRLF-TVIXENOKSA-N 0.000 description 1
• MUIWQCKLQMOUAT-AKUNNTHJSA-N bryostatin 20 Natural products COC(=O)C=C1C[C@@]2(C)C[C@]3(O)O[C@](C)(C[C@@H](O)CC(=O)O[C@](C)(C[C@@]4(C)O[C@](O)(CC5=CC(=O)O[C@]45C)C(C)(C)C=C[C@@](C)(C1)O2)[C@@H](C)O)C[C@H](OC(=O)C(C)(C)C)C3(C)C MUIWQCKLQMOUAT-AKUNNTHJSA-N 0.000 description 1
• 239000000872 buffer Substances 0.000 description 1
• 239000011575 calcium Substances 0.000 description 1
• 229910052791 calcium Inorganic materials 0.000 description 1
• 239000003710 calcium ionophore Substances 0.000 description 1
• 239000001506 calcium phosphate Substances 0.000 description 1
• 229910000389 calcium phosphate Inorganic materials 0.000 description 1
• 235000011010 calcium phosphates Nutrition 0.000 description 1
• 244000309466 calf Species 0.000 description 1
• 238000002619 cancer immunotherapy Methods 0.000 description 1
• 239000012830 cancer therapeutic Substances 0.000 description 1
• 230000000711 cancerogenic effect Effects 0.000 description 1
• 210000000234 capsid Anatomy 0.000 description 1
• 239000002041 carbon nanotube Substances 0.000 description 1
• 229910021393 carbon nanotube Inorganic materials 0.000 description 1
• 231100000315 carcinogenic Toxicity 0.000 description 1
• 150000001768 cations Chemical class 0.000 description 1
• 230000005779 cell damage Effects 0.000 description 1
• 230000003915 cell function Effects 0.000 description 1
• 230000009028 cell transition Effects 0.000 description 1
• 230000006800 cellular catabolic process Effects 0.000 description 1
• 230000007248 cellular mechanism Effects 0.000 description 1
• 239000001913 cellulose Substances 0.000 description 1
• 229920002678 cellulose Polymers 0.000 description 1
• 201000010881 cervical cancer Diseases 0.000 description 1
• 238000007385 chemical modification Methods 0.000 description 1
• 239000003638 chemical reducing agent Substances 0.000 description 1
• 238000002512 chemotherapy Methods 0.000 description 1
• 210000003483 chromatin Anatomy 0.000 description 1
• 239000013611 chromosomal DNA Substances 0.000 description 1
• 230000001684 chronic effect Effects 0.000 description 1
• 208000032852 chronic lymphocytic leukemia Diseases 0.000 description 1
• 230000006329 citrullination Effects 0.000 description 1
• 230000007699 co-inhibitory pathway Effects 0.000 description 1
• 238000012761 co-transfection Methods 0.000 description 1
• 229920001436 collagen Polymers 0.000 description 1
• 208000029742 colonic neoplasm Diseases 0.000 description 1
• 230000021615 conjugation Effects 0.000 description 1
• 101150055601 cops2 gene Proteins 0.000 description 1
• 238000012937 correction Methods 0.000 description 1
• 230000000139 costimulatory effect Effects 0.000 description 1
• 238000012258 culturing Methods 0.000 description 1
• 210000004292 cytoskeleton Anatomy 0.000 description 1
• IBOVDNBDQHYNJI-UHFFFAOYSA-N dabcyl SE dye Chemical compound C1=CC(N(C)C)=CC=C1N=NC1=CC=C(C(=O)ON2C(CCC2=O)=O)C=C1 IBOVDNBDQHYNJI-UHFFFAOYSA-N 0.000 description 1
• 230000006378 damage Effects 0.000 description 1
• 230000034994 death Effects 0.000 description 1
• 239000000412 dendrimer Substances 0.000 description 1
• 229920000736 dendritic polymer Polymers 0.000 description 1
• 239000005549 deoxyribonucleoside Substances 0.000 description 1
• 239000005547 deoxyribonucleotide Substances 0.000 description 1
• 125000002637 deoxyribonucleotide group Chemical group 0.000 description 1
• 230000030609 dephosphorylation Effects 0.000 description 1
• 238000006209 dephosphorylation reaction Methods 0.000 description 1
• 239000008121 dextrose Substances 0.000 description 1
• 238000010790 dilution Methods 0.000 description 1
• 239000012895 dilution Substances 0.000 description 1
• XPPKVPWEQAFLFU-UHFFFAOYSA-J diphosphate(4-) Chemical compound [O-]P([O-])(=O)OP([O-])([O-])=O XPPKVPWEQAFLFU-UHFFFAOYSA-J 0.000 description 1
• 235000011180 diphosphates Nutrition 0.000 description 1
• 201000010099 disease Diseases 0.000 description 1
• 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 description 1
• 238000012377 drug delivery Methods 0.000 description 1
• 210000000959 ear middle Anatomy 0.000 description 1
• 210000001163 endosome Anatomy 0.000 description 1
• 108010048367 enhanced green fluorescent protein Proteins 0.000 description 1
• 230000002708 enhancing effect Effects 0.000 description 1
• 230000006862 enzymatic digestion Effects 0.000 description 1
• 230000002255 enzymatic effect Effects 0.000 description 1
• 238000006911 enzymatic reaction Methods 0.000 description 1
• CJAONIOAQZUHPN-KKLWWLSJSA-N ethyl 12-[[2-[(2r,3r)-3-[2-[(12-ethoxy-12-oxododecyl)-methylamino]-2-oxoethoxy]butan-2-yl]oxyacetyl]-methylamino]dodecanoate Chemical compound CCOC(=O)CCCCCCCCCCCN(C)C(=O)CO[C@H](C)[C@@H](C)OCC(=O)N(C)CCCCCCCCCCCC(=O)OCC CJAONIOAQZUHPN-KKLWWLSJSA-N 0.000 description 1
• 208000024519 eye neoplasm Diseases 0.000 description 1
• 210000004700 fetal blood Anatomy 0.000 description 1
• 230000001605 fetal effect Effects 0.000 description 1
• 239000007850 fluorescent dye Substances 0.000 description 1
• 125000001153 fluoro group Chemical group F* 0.000 description 1
• 210000000232 gallbladder Anatomy 0.000 description 1
• 201000007487 gallbladder carcinoma Diseases 0.000 description 1
• 239000008273 gelatin Substances 0.000 description 1
• 229920000159 gelatin Polymers 0.000 description 1
• 235000019322 gelatine Nutrition 0.000 description 1
• 235000011852 gelatine desserts Nutrition 0.000 description 1
• 238000001415 gene therapy Methods 0.000 description 1
• 230000005017 genetic modification Effects 0.000 description 1
• 230000030414 genetic transfer Effects 0.000 description 1
• 235000013617 genetically modified food Nutrition 0.000 description 1
• 210000004602 germ cell Anatomy 0.000 description 1
• 239000008103 glucose Substances 0.000 description 1
• 230000013595 glycosylation Effects 0.000 description 1
• 238000006206 glycosylation reaction Methods 0.000 description 1
• 239000008187 granular material Substances 0.000 description 1
• 210000004209 hair Anatomy 0.000 description 1
• 208000014829 head and neck neoplasm Diseases 0.000 description 1
• 201000005787 hematologic cancer Diseases 0.000 description 1
• 230000009033 hematopoietic malignancy Effects 0.000 description 1
• 230000013632 homeostatic process Effects 0.000 description 1
• 229940088597 hormone Drugs 0.000 description 1
• 239000005556 hormone Substances 0.000 description 1
• 102000055302 human MDM2 Human genes 0.000 description 1
• 230000008348 humoral response Effects 0.000 description 1
• 230000007062 hydrolysis Effects 0.000 description 1
• 238000006460 hydrolysis reaction Methods 0.000 description 1
• 201000006866 hypopharynx cancer Diseases 0.000 description 1
• 210000000987 immune system Anatomy 0.000 description 1
• 230000003053 immunization Effects 0.000 description 1
• 230000001506 immunosuppresive effect Effects 0.000 description 1
• 230000001976 improved effect Effects 0.000 description 1
• 238000000099 in vitro assay Methods 0.000 description 1
• 230000000977 initiatory effect Effects 0.000 description 1
• 208000014674 injury Diseases 0.000 description 1
• 230000010507 innate immune sensing pathway Effects 0.000 description 1
• 229940125396 insulin Drugs 0.000 description 1
• 229960001388 interferon-beta Drugs 0.000 description 1
• 229940047124 interferons Drugs 0.000 description 1
• 210000003963 intermediate filament Anatomy 0.000 description 1
• 230000004068 intracellular signaling Effects 0.000 description 1
• 210000003228 intrahepatic bile duct Anatomy 0.000 description 1
• 230000009545 invasion Effects 0.000 description 1
• 238000002955 isolation Methods 0.000 description 1
• FZWBNHMXJMCXLU-BLAUPYHCSA-N isomaltotriose Chemical compound O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1OC[C@@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O)O1 FZWBNHMXJMCXLU-BLAUPYHCSA-N 0.000 description 1
• 238000006317 isomerization reaction Methods 0.000 description 1
• 238000011005 laboratory method Methods 0.000 description 1
• 239000008101 lactose Substances 0.000 description 1
• 206010023841 laryngeal neoplasm Diseases 0.000 description 1
• 201000004962 larynx cancer Diseases 0.000 description 1
• 239000004816 latex Substances 0.000 description 1
• 229920000126 latex Polymers 0.000 description 1
• 239000007788 liquid Substances 0.000 description 1
• 231100000053 low toxicity Toxicity 0.000 description 1
• 210000001165 lymph node Anatomy 0.000 description 1
• 230000000527 lymphocytic effect Effects 0.000 description 1
• 239000011777 magnesium Substances 0.000 description 1
• 229910052749 magnesium Inorganic materials 0.000 description 1
• 230000005291 magnetic effect Effects 0.000 description 1
• 238000012423 maintenance Methods 0.000 description 1
• 230000014759 maintenance of location Effects 0.000 description 1
• 230000003211 malignant effect Effects 0.000 description 1
• 208000006178 malignant mesothelioma Diseases 0.000 description 1
• 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 1
• 208000025848 malignant tumor of nasopharynx Diseases 0.000 description 1
• 208000026037 malignant tumor of neck Diseases 0.000 description 1
• 239000000594 mannitol Substances 0.000 description 1
• 235000010355 mannitol Nutrition 0.000 description 1
• 201000006512 mast cell neoplasm Diseases 0.000 description 1
• 208000006971 mastocytoma Diseases 0.000 description 1
• 239000011159 matrix material Substances 0.000 description 1
• 230000035800 maturation Effects 0.000 description 1
• 238000005259 measurement Methods 0.000 description 1
• 210000000713 mesentery Anatomy 0.000 description 1
• 230000009401 metastasis Effects 0.000 description 1
• YACKEPLHDIMKIO-UHFFFAOYSA-N methylphosphonic acid Chemical compound CP(O)(O)=O YACKEPLHDIMKIO-UHFFFAOYSA-N 0.000 description 1
• 239000002679 microRNA Substances 0.000 description 1
• 239000011325 microbead Substances 0.000 description 1
• 210000003632 microfilament Anatomy 0.000 description 1
• 239000004005 microsphere Substances 0.000 description 1
• 210000004688 microtubule Anatomy 0.000 description 1
• 201000003956 middle ear cancer Diseases 0.000 description 1
• 230000005012 migration Effects 0.000 description 1
• 238000013508 migration Methods 0.000 description 1
• 239000002480 mineral oil Substances 0.000 description 1
• 235000010446 mineral oil Nutrition 0.000 description 1
• 239000000178 monomer Substances 0.000 description 1
• 125000004573 morpholin-4-yl group Chemical group N1(CCOCC1)* 0.000 description 1
• 230000000877 morphologic effect Effects 0.000 description 1
• 238000010172 mouse model Methods 0.000 description 1
• 210000000214 mouth Anatomy 0.000 description 1
• 201000000050 myeloid neoplasm Diseases 0.000 description 1
• 239000002105 nanoparticle Substances 0.000 description 1
• 210000003928 nasal cavity Anatomy 0.000 description 1
• 201000007425 nasal cavity carcinoma Diseases 0.000 description 1
• 201000011216 nasopharynx carcinoma Diseases 0.000 description 1
• 229910052754 neon Inorganic materials 0.000 description 1
• GKAOGPIIYCISHV-UHFFFAOYSA-N neon atom Chemical compound [Ne] GKAOGPIIYCISHV-UHFFFAOYSA-N 0.000 description 1
• 230000009635 nitrosylation Effects 0.000 description 1
• 108091027963 non-coding RNA Proteins 0.000 description 1
• 102000042567 non-coding RNA Human genes 0.000 description 1
• 238000003199 nucleic acid amplification method Methods 0.000 description 1
• 201000008106 ocular cancer Diseases 0.000 description 1
• 210000002747 omentum Anatomy 0.000 description 1
• 231100000590 oncogenic Toxicity 0.000 description 1
• 230000002246 oncogenic effect Effects 0.000 description 1
• 238000011275 oncology therapy Methods 0.000 description 1
• 230000003647 oxidation Effects 0.000 description 1
• 238000007254 oxidation reaction Methods 0.000 description 1
• 201000002528 pancreatic cancer Diseases 0.000 description 1
• 208000008443 pancreatic carcinoma Diseases 0.000 description 1
• 230000006320 pegylation Effects 0.000 description 1
• 229940049954 penicillin Drugs 0.000 description 1
• 210000005259 peripheral blood Anatomy 0.000 description 1
• 239000011886 peripheral blood Substances 0.000 description 1
• 210000003819 peripheral blood mononuclear cell Anatomy 0.000 description 1
• 230000002093 peripheral effect Effects 0.000 description 1
• 210000004303 peritoneum Anatomy 0.000 description 1
• 230000003094 perturbing effect Effects 0.000 description 1
• 239000003208 petroleum Substances 0.000 description 1
• 201000008006 pharynx cancer Diseases 0.000 description 1
• 125000002467 phosphate group Chemical group [H]OP(=O)(O[H])O[*] 0.000 description 1
• UEZVMMHDMIWARA-UHFFFAOYSA-M phosphonate Chemical compound [O-]P(=O)=O UEZVMMHDMIWARA-UHFFFAOYSA-M 0.000 description 1
• 230000026731 phosphorylation Effects 0.000 description 1
• 238000006366 phosphorylation reaction Methods 0.000 description 1
• 125000005642 phosphothioate group Chemical group 0.000 description 1
• 230000001766 physiological effect Effects 0.000 description 1
• 108010058237 plasma protein fraction Proteins 0.000 description 1
• 229940002993 plasmanate Drugs 0.000 description 1
• 210000004224 pleura Anatomy 0.000 description 1
• 201000003437 pleural cancer Diseases 0.000 description 1
• 239000004584 polyacrylic acid Substances 0.000 description 1
• 230000008488 polyadenylation Effects 0.000 description 1
• 230000008092 positive effect Effects 0.000 description 1
• 230000001124 posttranscriptional effect Effects 0.000 description 1
• 230000001566 pro-viral effect Effects 0.000 description 1
• 230000005522 programmed cell death Effects 0.000 description 1
• 210000002307 prostate Anatomy 0.000 description 1
• 201000001514 prostate carcinoma Diseases 0.000 description 1
• 230000017854 proteolysis Effects 0.000 description 1
• 230000005588 protonation Effects 0.000 description 1
• 238000011002 quantification Methods 0.000 description 1
• 239000002096 quantum dot Substances 0.000 description 1
• 238000001959 radiotherapy Methods 0.000 description 1
• 230000009257 reactivity Effects 0.000 description 1
• 238000003753 real-time PCR Methods 0.000 description 1
• 238000011084 recovery Methods 0.000 description 1
• 206010038038 rectal cancer Diseases 0.000 description 1
• 210000000664 rectum Anatomy 0.000 description 1
• 201000001275 rectum cancer Diseases 0.000 description 1
• 230000010076 replication Effects 0.000 description 1
• 230000003362 replicative effect Effects 0.000 description 1
• 238000011160 research Methods 0.000 description 1
• 230000000284 resting effect Effects 0.000 description 1
• 239000002336 ribonucleotide Substances 0.000 description 1
• 125000002652 ribonucleotide group Chemical group 0.000 description 1
• 108091092562 ribozyme Proteins 0.000 description 1
• 238000012216 screening Methods 0.000 description 1
• 125000003607 serino group Chemical group [H]N([H])[C@]([H])(C(=O)[*])C(O[H])([H])[H] 0.000 description 1
• 239000002924 silencing RNA Substances 0.000 description 1
• 238000009097 single-agent therapy Methods 0.000 description 1
• 108091069025 single-strand RNA Proteins 0.000 description 1
• 201000000849 skin cancer Diseases 0.000 description 1
• 201000002314 small intestine cancer Diseases 0.000 description 1
• 150000003384 small molecules Chemical class 0.000 description 1
• 239000011780 sodium chloride Substances 0.000 description 1
• 229940054269 sodium pyruvate Drugs 0.000 description 1
• 239000007790 solid phase Substances 0.000 description 1
• 238000010532 solid phase synthesis reaction Methods 0.000 description 1
• 230000000392 somatic effect Effects 0.000 description 1
• 239000000600 sorbitol Substances 0.000 description 1
• 239000012798 spherical particle Substances 0.000 description 1
• 210000000952 spleen Anatomy 0.000 description 1
• 230000006641 stabilisation Effects 0.000 description 1
• 238000011105 stabilization Methods 0.000 description 1
• 239000008107 starch Substances 0.000 description 1
• 235000019698 starch Nutrition 0.000 description 1
• 229960005322 streptomycin Drugs 0.000 description 1
• 239000005720 sucrose Substances 0.000 description 1
• 230000019635 sulfation Effects 0.000 description 1
• 238000005670 sulfation reaction Methods 0.000 description 1
• 239000004094 surface-active agent Substances 0.000 description 1
• 238000001356 surgical procedure Methods 0.000 description 1
• 230000004083 survival effect Effects 0.000 description 1
• 201000003120 testicular cancer Diseases 0.000 description 1
• 229930101283 tetracycline Natural products 0.000 description 1
• 229960002180 tetracycline Drugs 0.000 description 1
• 235000019364 tetracycline Nutrition 0.000 description 1
• 150000003522 tetracyclines Chemical class 0.000 description 1
• ZRKFYGHZFMAOKI-QMGMOQQFSA-N tgfbeta Chemical compound C([C@H](NC(=O)[C@H](C(C)C)NC(=O)CNC(=O)[C@H](CCC(O)=O)NC(=O)[C@H](CCCNC(N)=N)NC(=O)[C@H](CC(N)=O)NC(=O)[C@H](CC(C)C)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CCC(O)=O)NC(=O)[C@H]([C@@H](C)O)NC(=O)[C@H](CC(C)C)NC(=O)CNC(=O)[C@H](C)NC(=O)[C@H](CO)NC(=O)[C@H](CCC(N)=O)NC(=O)[C@@H](NC(=O)[C@H](C)NC(=O)[C@H](C)NC(=O)[C@@H](NC(=O)[C@H](CC(C)C)NC(=O)[C@@H](N)CCSC)C(C)C)[C@@H](C)CC)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](C(C)C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](C)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H]([C@@H](C)O)C(=O)N[C@@H](CC(N)=O)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](C)C(=O)N[C@@H](CC=1C=CC=CC=1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](C)C(=O)N[C@@H](CC(C)C)C(=O)N1[C@@H](CCC1)C(=O)N1[C@@H](CCC1)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CCC(O)=O)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CO)C(=O)N[C@@H](CCCNC(N)=N)C(=O)N[C@@H](CC(C)C)C(=O)N[C@@H](CC(C)C)C(O)=O)C1=CC=C(O)C=C1 ZRKFYGHZFMAOKI-QMGMOQQFSA-N 0.000 description 1
• YAHHPOUXPBUKTL-DXKBKMAZSA-N thymidine dimer Chemical compound CC12C(C3N([C@H]4C[C@H](O)[C@@H](CO)O4)C(=O)NC(=O)C13C)N([C@H]1C[C@H](O)[C@@H](CO)O1)C(=O)NC2=O YAHHPOUXPBUKTL-DXKBKMAZSA-N 0.000 description 1
• 210000001541 thymus gland Anatomy 0.000 description 1
• 230000000451 tissue damage Effects 0.000 description 1
• 231100000827 tissue damage Toxicity 0.000 description 1
• 230000009466 transformation Effects 0.000 description 1
• 238000011830 transgenic mouse model Methods 0.000 description 1
• 230000001052 transient effect Effects 0.000 description 1
• 238000003146 transient transfection Methods 0.000 description 1
• QORWJWZARLRLPR-UHFFFAOYSA-H tricalcium bis(phosphate) Chemical compound [Ca+2].[Ca+2].[Ca+2].[O-]P([O-])([O-])=O.[O-]P([O-])([O-])=O QORWJWZARLRLPR-UHFFFAOYSA-H 0.000 description 1
• 239000013638 trimer Substances 0.000 description 1
• 235000011178 triphosphate Nutrition 0.000 description 1
• UNXRWKVEANCORM-UHFFFAOYSA-N triphosphoric acid Chemical compound OP(O)(=O)OP(O)(=O)OP(O)(O)=O UNXRWKVEANCORM-UHFFFAOYSA-N 0.000 description 1
• 230000010415 tropism Effects 0.000 description 1
• 230000005909 tumor killing Effects 0.000 description 1
• OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 1
• 125000001493 tyrosinyl group Chemical group [H]OC1=C([H])C([H])=C(C([H])=C1[H])C([H])([H])C([H])(N([H])[H])C(*)=O 0.000 description 1
• 238000010798 ubiquitination Methods 0.000 description 1
• KJIOQYGWTQBHNH-UHFFFAOYSA-N undecanol Chemical compound CCCCCCCCCCCO KJIOQYGWTQBHNH-UHFFFAOYSA-N 0.000 description 1
• 241001515965 unidentified phage Species 0.000 description 1
• 241001430294 unidentified retrovirus Species 0.000 description 1
• 238000011144 upstream manufacturing Methods 0.000 description 1
• 201000011294 ureter cancer Diseases 0.000 description 1
• 230000002477 vacuolizing effect Effects 0.000 description 1
• 210000005166 vasculature Anatomy 0.000 description 1
• 235000015112 vegetable and seed oil Nutrition 0.000 description 1
• 239000008158 vegetable oil Substances 0.000 description 1
• 108700001624 vesicular stomatitis virus G Proteins 0.000 description 1
• 108700026220 vif Genes Proteins 0.000 description 1
• 230000010464 virion assembly Effects 0.000 description 1
• 229940088594 vitamin Drugs 0.000 description 1
• 229930003231 vitamin Natural products 0.000 description 1
• 235000013343 vitamin Nutrition 0.000 description 1
• 239000011782 vitamin Substances 0.000 description 1
• XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 1